View Filing Data

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Mar. 28, 2020	May 12, 2020	Sep. 28, 2019
Document and Entity Information [Abstract]
Document Annual Report	true
City Area Code	336
Local Phone Number	664-1233
Title of 12(b) Security	Common Stock, $0.0001 par value
Entity Incorporation, State or Country Code	DE
Document Transition Report	false
Entity Registrant Name	Qorvo, Inc.
Entity Central Index Key	0001604778
Document Type	10-K
Entity File Number	001-36801
Document Period End Date	Mar. 28, 2020
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--03-28
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Internal Control over Financial Reporting filed report	true
Entity Shell Company	false
Entity Small Business	false
Entity Public Float			$ 8,484,359,696
Entity Common Stock, Shares Outstanding		114,734,210
Entity Tax Identification Number	46-5288992
Entity Address, Address Line One	7628 Thorndike Road
Entity Address, Postal Zip Code	27409-9421
Entity Address, City or Town	Greensboro,
Entity Address, State or Province	NC
Trading Symbol	QRVO
Security Exchange Name	NASDAQ

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019
Current assets:
Cash and cash equivalents	$ 714,939	$ 711,035
Accounts receivable, less allowance of $55 and $40 as of March 28, 2020 and March 30, 2019, respectively	367,172	378,172
Inventories	517,198	511,793
Prepaid expenses	37,872	25,766
Other receivables	15,016	21,934
Other current assets	38,305	36,141
Total current assets	1,690,502	1,684,841
Property and equipment, net	1,259,203	1,366,513
Goodwill	2,614,274	2,173,889
Intangible assets, net	808,892	408,210
Long-term investments	22,515	97,786
Other non-current assets	165,296	76,785
Total assets	6,560,682	5,808,024
Current liabilities:
Accounts payable	246,954	233,307
Accrued liabilities	217,801	160,516
Current portion of long-term debt	6,893	80
Other current liabilities	67,355	41,711
Total current liabilities	539,003	435,614
Long-term debt	1,567,231	920,935
Other long-term liabilities	161,783	91,796
Total liabilities	2,268,017	1,448,345
Commitments and contingent liabilities
Stockholders’ equity:
Preferred stock, $.0001 par value; 5,000 shares authorized; no shares issued and outstanding	0	0
Common stock and additional paid-in capital, $.0001 par value; 405,000 shares authorized; 114,625 and 119,063 shares issued and outstanding at March 28, 2020 and March 30, 2019, respectively	4,290,377	4,687,455
Accumulated other comprehensive income (loss), net of tax	2,288	(6,624)
Accumulated deficit	0	(321,152)
Total stockholders’ equity	4,292,665	4,359,679
Total liabilities and stockholders’ equity	$ 6,560,682	$ 5,808,024

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019
Statement of Financial Position [Abstract]
Allowance for accounts receivable	$ 55	$ 40
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common stock, shares authorized	405,000,000	405,000,000
Common stock, shares issued	114,625,000	119,063,000
Common stock, shares outstanding	114,625,000	119,063,000

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Income Statement [Abstract]
Revenue	$ 3,239,141	$ 3,090,325	$ 2,973,536
Cost of goods sold	1,917,378	1,895,142	1,826,570
Gross profit	1,321,763	1,195,183	1,146,966
Operating expenses:
Research and development	484,414	450,482	445,103
Selling, general and administrative	343,569	476,074	527,751
Other operating expense	70,564	52,161	103,830
Total operating expenses	898,547	978,717	1,076,684
Operating income	423,216	216,466	70,282
Interest expense	(60,392)	(43,963)	(59,548)
Interest income	12,066	10,971	7,017
Other income (expense)	20,199	(91,682)	(606)
Income before income taxes	395,089	91,792	17,145
Income tax (expense) benefit	60,764	(41,333)	57,433
Net income (loss)	$ 334,325	$ 133,125	$ (40,288)
Net income (loss) per share:
Basic	$ 2.86	$ 1.07	$ (0.32)
Diluted	$ 2.80	$ 1.05	$ (0.32)
Weighted average shares of common stock outstanding:
Basic	117,007	124,534	126,946
Diluted	119,293	127,356	126,946

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 334,325	$ 133,125	$ (40,288)
Total comprehensive income (loss):
Unrealized gain on available-for-sale debt securities, net of tax	0	85	204
Change in pension liability, net of tax	501	(651)	476
Foreign currency translation adjustment, including intra-entity foreign currency transactions that are of a long-term-investment nature	7,923	(3,396)	1,276
Reclassification adjustments, net of tax:
Foreign currency loss (gain) recognized and included in net income (loss)	353	0	(581)
Amortization of pension actuarial loss	135	90	179
Other comprehensive income (loss)	8,912	(3,872)	1,554
Total comprehensive income (loss)	$ 343,237	$ 129,253	$ (38,734)

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit
Common Stocks, Including Additional Paid in Capital	$ 5,357,394
Accumulated Other Comprehensive Income (Loss), Net of Tax	(4,306)
Retained Earnings (Accumulated Deficit)	(456,366)
Beginning Balance at Apr. 01, 2017	$ 4,896,722
Beginning Balance, Shares at Apr. 01, 2017	126,464
Net income (loss)	$ (40,288)	$ 0	$ 0	$ (40,288)
Other comprehensive income (loss)	1,554	0	1,554	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ 4,735	4,735	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	2,246
Issuance of common stock in connection with employee stock purchase plan	$ 28,064	28,064	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	541
Cumulative-effect adoption of ASU 2016-09	$ 36,684	0	0	36,684
Cumulative-effect adoption of ASU 2016-16	1,201	0	0	1,201
Repurchase of common stock, including transaction costs	(219,907)	(219,907)	0	0
Stock-based compensation expense	$ 66,799	66,799	0	0
Repurchase of common stock, including transaction costs, Shares	(2,929)
Ending Balance at Mar. 31, 2018	$ 4,775,564
Ending Balance, Shares at Mar. 31, 2018	126,322
Common Stocks, Including Additional Paid in Capital	$ 5,237,085
Accumulated Other Comprehensive Income (Loss), Net of Tax	(2,752)
Retained Earnings (Accumulated Deficit)	(458,769)
Net income (loss)	133,125	0	0	133,125
Other comprehensive income (loss)	(3,872)	0	(3,872)	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (10,833)	(10,833)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	1,368
Issuance of common stock in connection with employee stock purchase plan	$ 26,817	26,817	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	468
Repurchase of common stock, including transaction costs	$ (638,074)	(638,074)	0	0
Stock-based compensation expense	72,460	72,460	0	0
Cumulative-effect adoption of ASU 2014-09	$ 4,492	0	0	4,492
Repurchase of common stock, including transaction costs, Shares	(9,095)
Ending Balance at Mar. 30, 2019	$ 4,359,679
Ending Balance, Shares at Mar. 30, 2019	119,063
Common Stocks, Including Additional Paid in Capital	$ 4,687,455
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,624)
Retained Earnings (Accumulated Deficit)	(321,152)
Net income (loss)	334,325	0	0	334,325
Other comprehensive income (loss)	8,912	0	8,912	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes	$ (974)	(974)	0	0
Exercise of stock options and vesting of restricted stock units, net of shares withheld for employee taxes, Shares	1,551
Issuance of common stock in connection with employee stock purchase plan	$ 28,657	28,657	0	0
Issuance of common stock in connection with employee stock purchase plan, Shares	452
Repurchase of common stock, including transaction costs	$ (515,131)	(501,868)	0	(13,263)
Stock-based compensation expense	77,107	77,107	0	0
Cumulative-effect adoption of ASU 2016-02	$ 69	0	0	69
Repurchase of common stock, including transaction costs, Shares	(6,441)
Other Retained Earnings Adjustment	$ 21	$ 0	$ 0	$ 21
Ending Balance at Mar. 28, 2020	$ 4,292,665
Ending Balance, Shares at Mar. 28, 2020	114,625
Common Stocks, Including Additional Paid in Capital	$ 4,290,377
Accumulated Other Comprehensive Income (Loss), Net of Tax	2,288
Retained Earnings (Accumulated Deficit)	$ 0

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Statement of Cash Flows [Abstract]
Interest Paid, Excluding Capitalized Interest, Operating Activities	$ 54,445	$ 64,853	$ 70,208
Cash flows from operating activities:
Net income (loss)	334,325	133,125	(40,288)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	221,632	208,646	174,425
Intangible assets amortization	247,299	454,451	539,790
Loss on debt extinguishment	0	90,201	928
Deferred income taxes	(11,099)	(70,169)	(32,248)
Foreign currency adjustments	1,300	2,376	(953)
Gain on Cavendish investment	(43,008)	0	0
Loss on impairment of equity investment	18,339	0	0
Asset impairment	1,057	15,901	46,315
Stock-based compensation expense	75,978	71,580	68,158
Other, net	10,178	5,087	3,792
Changes in operating assets and liabilities:
Accounts receivable, net	21,029	(32,119)	12,906
Inventories	10,252	(39,590)	(41,887)
Prepaid expenses and other current and non-current assets	(14,513)	13,343	28,310
Accounts payable	15,425	15,167	38,952
Accrued liabilities	48,670	(3,899)	(2,623)
Income taxes payable and receivable	12,935	(38,206)	50,801
Other liabilities	(1,553)	(10,778)	4,236
Net cash provided by operating activities	945,646	810,364	852,520
Investing activities:
Purchase of property and equipment	(164,104)	(220,937)	(269,835)
Purchase of available-for-sale debt securities	0	(132,732)	0
Proceeds from sales and maturities of available-for-sale debt securities	1,950	133,132	0
Purchase of businesses, net of cash acquired	(946,043)	0	0
Other investing	2,455	(27,017)	(7,574)
Net cash used in investing activities	(1,105,742)	(247,554)	(277,409)
Financing activities:
Repurchase and payment of debt	0	(1,050,680)	(107,729)
Proceeds from borrowings and debt issuances	659,000	905,350	100,000
Repurchase of common stock, including transaction costs	(515,131)	(638,074)	(219,907)
Proceeds from the issuance of common stock	50,198	41,289	57,412
Tax withholding paid on behalf of employees for restricted stock units	(21,791)	(24,835)	(24,708)
Other financing	(6,717)	(9,714)	(1,916)
Net cash provided by (used in) financing activities	165,559	(776,664)	(196,848)
Effect of exchange rate changes on cash	(1,233)	(1,166)	2,360
Net increase (decrease) in cash, cash equivalents and restricted cash	4,230	(215,020)	380,623
Cash, cash equivalents and restricted cash at the beginning of the period	711,382	926,402	545,779
Cash, cash equivalents and restricted cash at the end of the period	715,612	711,382	926,402
Supplemental disclosure of cash flow information:
Cash paid during the year for income taxes	55,513	69,453	41,478
Non-cash investing and financing information:
Capital expenditure adjustments included in liabilities	$ 22,904	$ 37,728	$ 31,769

The Company and Its Significant Accounting Policies

12 Months Ended

Mar. 28, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

THE COMPANY AND ITS SIGNIFICANT ACCOUNTING POLICIES

Qorvo, Inc. was formed as the result of a business combination (the "Business Combination") of RF Micro Devices, Inc. ("RFMD") and TriQuint Semiconductor, Inc. ("TriQuint"), which closed on January 1, 2015.

The Company is a leader in the development and commercialization of technologies and products for wireless and wired connectivity. The Company combines a broad portfolio of innovative radio frequency ("RF") solutions, highly differentiated semiconductor technologies, systems-level expertise and global manufacturing scale to supply diverse customers a broad range of products that enable a more connected world.

The Company’s design expertise and manufacturing capabilities span multiple semiconductor process technologies. The Company's primary wafer fabrication facilities are located in North Carolina, Oregon and Texas and its primary assembly and test facilities are located in China, Costa Rica, Germany and Texas. The Company also sources multiple products and materials through external suppliers. The Company operates design, sales and other manufacturing facilities throughout Asia, Europe and North America.

Principles of Consolidation and Basis of Presentation

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain items in the fiscal years 2019 and 2018 financial statements have been reclassified to conform to the fiscal 2020 presentation.

Accounting Periods

The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The most recent three fiscal years ended on March 28, 2020, March 30, 2019 and March 31, 2018. Fiscal years 2020, 2019 and 2018 were 52-week years.

Use of Estimates

The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and the disclosure of contingent liabilities. The Company evaluates its estimates on an ongoing basis, including those related to revenue recognition, product warranty obligations, valuation of inventories, tax related contingencies, valuation of long-lived and intangible assets, other contingencies and litigation, among others. The Company generally bases its estimates on historical experience, expected future conditions and third-party evaluations. Accounting estimates require difficult and subjective judgments and actual results may differ from the Company’s estimates, particularly in light of the uncertainty relating to the impact of the recent novel coronavirus (COVID-19) outbreak. Certain accounting estimates that generally require consideration of expected future conditions were assessed by taking into account anticipated impacts from the COVID-19 outbreak as of March 28, 2020 and through the date of this Annual Report on Form 10-K using reasonably available information as of those dates.

Cash and Cash Equivalents

Cash and cash equivalents consist of demand deposit accounts, money market funds, and other temporary, highly-liquid investments with original maturities of three months or less when purchased.

Investments

The Company's available-for-sale debt securities (consisting of auction rate securities in fiscal 2019) are carried at fair value with the changes in unrealized gains and losses, net of tax, reported in "Other comprehensive income (loss)." The cost of securities sold is based on the specific identification method and any realized gain or loss is included in "Other income (expense)." The cost of available-for-sale debt securities is adjusted for premiums and discounts, with the amortization or accretion of such amounts included as a portion of interest. Available-for-sale debt securities with an original maturity date greater than three months and less than one year are classified as

current investments. Available-for-sale debt securities with an original maturity date exceeding one year are classified as long-term.

Marketable equity securities consist of common stock in publicly-traded companies and are carried at fair value with both the realized and unrealized gains and losses reported in "Other income (expense)." Fair values of publicly-traded equity securities are determined using quoted prices in active markets. The marketable equity securities are classified as short-term based on their highly liquid nature and are recorded in "Other current assets" in the Consolidated Balance Sheets.

The Company invests in limited partnerships which are accounted for using the equity method. These equity method investments are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company records its share of the financial results of the limited partnerships in "Other income (expense)" in the Company's Consolidated Statements of Operations.

The Company also invests in privately-held companies for which the fair value of the investment is not readily determinable. These equity investments without a readily determinable fair value are measured at cost less impairment, adjusted for any changes in observable prices, and are classified as "Long-term investments" in the Consolidated Balance Sheets. The Company assesses these investments for impairment on a quarterly basis and considers both qualitative and quantitative factors that may have a significant impact on the investee's fair value. Qualitative factors considered include the investee's financial condition and business outlook, market for technology and other relevant events and factors affecting the investee. Investments are impaired when their fair value is less than their carrying value.

Fair Value Measurement

The Company measures and reports certain financial assets and liabilities on a recurring basis. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes its financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is described as follows:


•	Level 1 - includes instruments for which inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.


•	Level 2 - includes instruments for which the inputs are other than quoted prices that are observable for the asset or liability, either directly or indirectly, and fair value can be determined through the use of models or other valuation methodologies that do not require significant judgment since the inputs are corroborated by readily observable data.


•	Level 3 - includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. These inputs are supported by little or no market activity and reflect the use of significant management judgment.

The Company also holds assets whose fair value is measured and recorded on a nonrecurring basis. These assets include equity method investments, equity investments without a readily determinable fair value, and certain non-financial assets, such as intangible assets and property and equipment. See Note 7 for further information on equity investments without a readily determinable fair value and Note 12 for further information on impairment of property and equipment.

The carrying values of cash and cash equivalents, accounts receivable, accounts payable and other accrued liabilities approximate fair values because of the relatively short-term maturities of these instruments. See Note 9 for further disclosures related to the fair value of the Company's long-term debt.

Inventories

Inventories are stated at the lower of cost or net realizable value (cost is based on standard cost, which approximates actual average cost). The Company’s business is subject to the risk of technological and design changes. The Company evaluates inventory levels quarterly against sales forecasts on a product family basis to evaluate its overall inventory risk. Reserves are adjusted to reflect inventory values in excess of forecasted sales and management's analysis and assessment of overall inventory risk. In the event the Company sells inventory that had been covered by a specific inventory reserve, the sale is recorded at the actual selling price and the related cost of goods sold is recorded at the full inventory cost, net of the reserve. Abnormal production levels are charged to "Cost of goods sold" in the period incurred rather than as a portion of inventory cost.

Product Warranty

The Company generally sells products with a limited warranty on product quality. The Company accrues for known warranty issues if a loss is probable and can be reasonably estimated and accrues for estimated incurred but unidentified issues based on historical activity. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing and the short time typically between product shipment and the detection and correction of product failures and the historical rate of losses, the accrual and related expense for estimated incurred but unidentified issues was also not significant during the periods presented.

Property and Equipment

Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the assets, ranging from one year to 39 years. The Company capitalizes interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated together with that asset cost. The Company’s assets acquired under finance leases and leasehold improvements are amortized over the lesser of the asset life or lease term (which is reasonably assured) and included in depreciation. The Company records capital-related government grants earned as a reduction to property and equipment and depreciates such grants over the estimated useful lives of the associated assets.

The Company periodically evaluates the period over which it expects to recover the economic value of the Company’s property and equipment, considering factors such as changes in machinery and equipment technology, the ability to re-use equipment across generations of process technology and historical usage trends. If the Company determines that the useful lives of its assets are shorter or longer than originally estimated, the rate of depreciation is adjusted to reflect the revised useful lives of the assets.

The Company assesses property and equipment for impairment when events or changes in circumstances indicate that the carrying amount of its assets may not be recoverable. Factors that are considered in deciding when to perform an impairment review include an adverse change in the use of the Company’s assets or an expectation that the assets will be sold or otherwise disposed. The Company assesses the recoverability of the assets held and used by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Assets identified as "held for sale" are recorded at the lesser of their carrying value or their fair market value less costs to sell. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.

Leases

The Company determines that a contract contains a lease at lease inception if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. In evaluating whether the right to control an identified asset exists, the Company assesses whether it has the right to direct the use of the identified asset and obtain substantially all of the economic benefit from the use of the identified asset.

Right-of-use assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate in determining the present value of lease payments considering the term of the lease, which is derived from information available at the lease commencement date. The lease term includes renewal options when it is reasonably certain that the option will be exercised and excludes termination options. To the extent that the Company's agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time.

Business Acquisitions

The Company records goodwill when the consideration paid for a business acquisition exceeds the estimated fair value of the net identified tangible and intangible assets acquired. Goodwill is assigned to the Company's reporting unit that is expected to benefit from the synergies of the business combination.

A number of assumptions, estimates and judgments are used in determining the fair value of acquired assets and liabilities, particularly with respect to the intangible assets acquired. The valuation of intangible assets requires the Company to use valuation techniques such as the income approach. The income approach includes management’s estimation of future cash flows (including expected revenue growth rates and profitability), the underlying product or technology life cycles and the discount rates applied to future cash flows.

Judgment is also required in estimating the fair values of deferred tax assets and liabilities, uncertain tax positions and tax-related valuation allowances, which are initially estimated as of the acquisition date, as well as inventory, property and equipment, pre-existing liabilities or legal claims, deferred revenue and contingent consideration, each as may be applicable.

While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, the Company’s estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recognized in the Consolidated Statements of Operations.

Goodwill

The Company performs an annual impairment assessment of goodwill at the reporting unit level on the first day of the fourth quarter in each fiscal year, or more frequently if indicators of potential impairment exist. Reporting units, as defined by Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 350, "Intangibles - Goodwill and Other," may be operating segments as a whole or an operation one level below an operating segment, referred to as a component. The Company has determined that its reporting units are its two operating and reportable segments, Mobile Products ("MP") and Infrastructure and Defense Products ("IDP").

In accordance with ASC 350, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill.

In performing a qualitative assessment, the Company considers (i) its overall historical and projected future operating results, (ii) if there was a significant decline in the Company’s stock price for a sustained period, (iii) if there was a significant change in the Company’s market capitalization relative to its net book value, and (iv) if there was a prolonged or more significant slowdown in the worldwide economy of the semiconductor industry, as well as

other relevant events and factors affecting the reporting unit. If the Company assesses these qualitative factors and concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, or if the Company decides not to perform a qualitative assessment, then a quantitative impairment test is performed.

In fiscal years 2019 and 2018, the Company completed qualitative assessments and concluded that based on the relevant facts and circumstances, it was more likely than not that each reporting unit’s fair value exceeded its related carrying value and no further impairment testing was required.

In fiscal 2020, the Company performed a quantitative impairment test. The Company’s quantitative impairment test considered both the income approach and the market approach to estimate each reporting unit’s fair value. Under the income approach, the fair value of each reporting unit is based on the present value of estimated future cash flows. Cash flow projections are based on the Company's estimates of revenue growth rates and operating margins, taking into consideration industry and market conditions. The discount rate used to determine the present value of future cash flows is based on the weighted-average cost of capital adjusted for the relevant risk associated with business-specific characteristics and the uncertainty related to the business's ability to execute on the projected cash flows. The market approach estimates fair value based on market multiples of revenue and earnings derived from comparable publicly traded companies with similar operating and investment characteristics. The resulting fair value, based on the income and market approaches, is then compared to the carrying value to determine if impairment is necessary.

As a result of the quantitative analysis performed in fiscal 2020, it was determined that the fair value of each of the Company’s reporting units substantially exceeded their carrying values. As the assumptions used in the income approach and market approach can have a material impact on the fair value determinations, the Company performed a sensitivity analysis of key assumptions used in the assessment and determined that a one percentage point increase in the discount rate along with a one percentage point decrease in the long-term growth rate would not result in an impairment of goodwill for either reporting unit and their fair values substantially exceeded their carrying values.

Identified Intangible Assets

The Company amortizes finite-lived intangible assets (including developed technology, customer relationships, trade names, technology licenses and backlog) over their estimated useful life. In-process research and development ("IPRD") assets represent the fair value of incomplete research and development ("R&D") projects that had not reached technological feasibility as of the date of the acquisition and are initially not subject to amortization. Upon completion of development, IPRD assets are transferred to developed technology and are amortized over their useful lives. The asset balances relating to abandoned projects are impaired and expensed to R&D. The Company performs a quarterly review of significant intangible assets to determine whether facts and circumstances (including external factors such as industry and economic trends and internal factors such as changes in the Company’s business strategy and forecasts) indicate that the carrying amount of the assets may not be recoverable. If such facts and circumstances exist, the Company assesses the recoverability of identified intangible assets by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amounts over the fair value of those assets and occur in the period in which the impairment determination was made.

Accrued Liabilities

The "Accrued liabilities" balance as of March 28, 2020 and March 30, 2019, includes accrued compensation and benefits of $126.1 million and $93.2 million, respectively, and interest payable of $22.8 million and $11.2 million, respectively.

Revenue Recognition

The Company generates revenue primarily from the sale of semiconductor products, either directly to a customer or to a distributor, or at completion of a consignment process. Revenue is recognized when control of the promised goods or services is transferred to the Company's customers, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. A majority of the Company's revenue is recognized at a point in time, either on shipment or delivery of the product, depending on individual customer terms and conditions. Revenue from sales to the Company’s distributors is recognized upon shipment of the product to the distributors (sell-in). Revenue is recognized from the Company’s consignment programs at a point in time when the products are pulled from consignment inventory by the customer. Revenue recognized for products and services over time is immaterial (less than 2% of overall revenue). The Company applies a five-step approach as defined in ASC 606, "Revenue from Contracts with Customers," in determining the amount and timing of revenue to be recognized: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to the performance obligations in the contract; and (5) recognizing revenue when the corresponding performance obligation is satisfied.

Sales agreements are in place with certain customers and contain terms and conditions with respect to payment, delivery, warranty and supply, but typically do not require minimum purchase commitments. In the absence of a sales agreement, the Company’s standard terms and conditions apply. The Company considers a customer's purchase order, which is governed by a sales agreement or the Company’s standard terms and conditions, to be the contract with the customer.

The Company’s pricing terms are negotiated independently, on a stand-alone basis. In determining the transaction price, the Company evaluates whether the price is subject to refund or adjustment to determine the net consideration to which the Company expects to be entitled. Variable consideration in the form of rebate programs is offered to certain customers, including distributors. A majority of these rebates are accrued and classified as a contra accounts receivable and represent less than 5% of net revenue. The Company determines variable consideration by estimating the most likely amount of consideration it expects to receive from the customer. The Company's terms and conditions do not give its customers a right of return associated with the original sale of its products. However, the Company may authorize sales returns under certain circumstances, which include courtesy returns and like-kind exchanges. Sales returns are classified as a refund liability. The Company reduces revenue and records reserves for product returns and allowances, rebate programs and scrap allowance based on historical experience or specific identification depending on the contractual terms of the arrangement.

The Company’s accounts receivable balance is from contracts with customers and represents the Company’s unconditional right to receive consideration from its customers. Payments are due upon completion of the performance obligation and subsequent invoicing. Substantially all payments are collected within the Company’s standard terms, which do not include any financing components. To date, there have been no material impairment losses on accounts receivable. Contract assets and contract liabilities recorded on the Consolidated Balance Sheets were immaterial as of March 28, 2020 and March 30, 2019.

The Company invoices customers upon shipment and recognizes revenues in accordance with delivery terms. As of March 28, 2020, the Company had $37.8 million in remaining unsatisfied performance obligations with an original duration greater than one year, of which the majority is expected to be recognized as income over the next 12 months.

The Company includes shipping charges billed to customers in "Revenue" and includes the related shipping costs in "Cost of goods sold" in the Consolidated Statements of Operations. Taxes assessed by government authorities on revenue-producing transactions, including tariffs, value-added and excise taxes, are excluded from revenue in the Consolidated Statements of Operations.

The Company incurs commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded in the "Selling, general and administrative" expense line item in the Consolidated Statements of Operations) are expensed when incurred because such commissions are not owed until the performance obligation is satisfied, which coincides with the end of the contract term, and therefore no remaining period exists over which to amortize the commissions.

Research and Development

The Company charges all R&D costs to expense as incurred.

Income Taxes

The Company accounts for income taxes under the liability method, which requires recognition of deferred tax assets and liabilities for the temporary differences between the financial reporting and tax basis of assets and liabilities and for tax carryforwards. Deferred tax assets and liabilities for each tax jurisdiction are measured using the enacted statutory tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is provided against deferred tax assets to the extent the Company determines it is more likely than not that some portion or all of its deferred tax assets will not be realized.

A more likely than not recognition threshold is required to be met before the Company recognizes the benefit of an income tax position in its financial statements. The Company’s policy is to recognize accrued interest and penalties, if incurred, on any unrecognized tax benefits as a component of income tax expense.

It is the Company’s current intent and policy to repatriate certain previously taxed earnings of foreign subsidiaries from outside the U.S. Accordingly, the Company recognizes a deferred tax liability for income taxes on certain unremitted foreign earnings of foreign subsidiaries. For earnings which remain permanently reinvested, it is not practical to estimate the additional tax that would be incurred, if any, if the permanently reinvested earnings were repatriated.

Stock-Based Compensation

Under ASC 718, "Compensation – Stock Compensation," stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period.

As of March 28, 2020, total remaining unearned compensation cost related to unvested restricted stock units was $87.4 million, which will be amortized over the weighted-average remaining service period of approximately 1.3 years.

Foreign Currency Translation

The financial statements of foreign subsidiaries have been translated into U.S. dollars in accordance with ASC 830, "Foreign Currency Matters." The functional currency for most of the Company’s international operations is the U.S. dollar. The functional currency for the remainder of the Company’s foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rates on the balance sheet dates. Revenues and expenses are translated using the average exchange rates throughout the year. Translation adjustments are shown separately as a component of "Accumulated other comprehensive income (loss)" within "Stockholders’ equity" in the Consolidated Balance Sheets. Foreign currency transaction gains or losses (transactions denominated in a currency other than the functional currency) are reported in "Other income (expense)" in the Consolidated Statements of Operations.

Recent Accounting Pronouncements

Accounting Pronouncements Not Yet Effective

In June 2016, the FASB issued Accounting Standards Update ("ASU") 2016-13, "Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments," which requires a current lifetime expected credit loss methodology to be used to measure impairments of accounts receivable and other financial assets. Using this methodology will result in earlier recognition of losses than under the current incurred loss approach, which requires waiting to recognize a loss until it is probable of being incurred. This standard will be effective for the Company in the first quarter of fiscal 2021 and will be adopted using the modified retrospective transition method. Upon adoption, the standard is expected to only impact the Company's accounting for credit losses related to accounts receivable. In preparation for the adoption of the new standard, the Company has updated certain policies and related processes, but does not expect the adoption of this new guidance will have a material impact on its Consolidated Financial Statements.

Accounting Pronouncements Recently Adopted

In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)," with multiple amendments subsequently issued. The new guidance required that lease arrangements be presented on the lessee's balance sheet by recording a right-of-use asset and a lease liability equal to the present value of the related future minimum lease payments. The Company adopted the standard in the first quarter of fiscal 2020, using the modified retrospective approach which permits lessees to recognize a cumulative-effect adjustment to the opening balance of accumulated deficit in the period of adoption. Upon adoption, the Company recorded a right-of-use asset of $70.7 million and a lease liability of $75.0 million. The difference between the right-of-use asset and lease liability is primarily attributed to a deferred rent liability which existed under ASC 840, "Leases."

The Company elected the transition package of practical expedients, under which the Company did not have to reassess (1) whether any expired or existing contracts are leases, or contain leases, (2) the lease classification for any expired or existing leases, and (3) initial direct costs for any existing leases. Further, the Company elected the practical expedient not to separate lease and non-lease components for substantially all of its classes of leases and to account for the combined lease and non-lease components as a single lease component. In addition, the Company made an accounting policy election to exclude leases with an initial term of 12 months or less from the balance sheet.

The adoption of this standard resulted in a cumulative-effect adjustment to accumulated deficit of less than $0.1 million. This standard did not have a material impact on the Consolidated Statements of Operations or Consolidated Statements of Cash Flows. See Note 8 for further disclosures resulting from the adoption of this new standard.

Concentrations of Credit Risk

12 Months Ended

Mar. 28, 2020

Risks and Uncertainties [Abstract]

CONCENTRATIONS OF CREDIT RISK

The Company’s principal financial instrument subject to potential concentration of credit risk is accounts receivable, which is unsecured. The Company provides an allowance for doubtful accounts equal to estimated losses expected to be incurred in the collection of accounts receivable. The Company has adopted credit policies and standards intended to accommodate industry growth and inherent risk and it believes that credit risks are moderated by the financial stability of its major customers, conservative payment terms and the Company’s strict credit policies.

Revenue from significant customers, those representing 10% or more of revenue for the respective periods, are summarized as follows:



	Fiscal Year
	2020	2019	2018
Apple Inc. ("Apple") (1)	33%	32%	36%
Huawei Technologies Co., Ltd. and affiliates ("Huawei")	10%	15%	8%

(1) The Company provided its products to Apple through sales to multiple contract manufacturers.

These customers primarily purchase RF solutions for a variety of mobile devices.

Accounts receivable related to these customers (which includes multiple contract manufacturers) accounted for 35%, 49% and 26% of the Company's total net accounts receivable balance as of March 28, 2020, March 30, 2019 and March 31, 2018, respectively.

On May 16, 2019, the Company suspended shipments of products to Huawei after the Bureau of Industry and Security (BIS) of the U.S. Department of Commerce added Huawei Technologies Co., Ltd. and over 100 of its affiliates to the BIS's Entity List. Subsequently, the Company restarted shipments from outside the U.S. of certain products that are not subject to the Export Administration Regulations (EAR) to Huawei in compliance with the BIS order. The Company has also applied for a license to ship other products that are subject to the EAR, as required by the rules governing the Entity List. Sales to Huawei will continue to be impacted by trade restrictions.

Inventories

12 Months Ended

Mar. 28, 2020

Inventory Disclosure [Abstract]

INVENTORIES

The components of inventories, net of reserves, are as follows (in thousands):



	March 28, 2020		March 30, 2019
Raw materials	$	112,671	$	118,608
Work in process	291,028		272,469
Finished goods	113,499		120,716
Total inventories	$	517,198	$	511,793

Property and Equipment

12 Months Ended

Mar. 28, 2020

Property, Plant and Equipment [Abstract]

Property and Equipment

PROPERTY AND EQUIPMENT

The components of property and equipment are as follows (in thousands):



	March 28, 2020			March 30, 2019
Land	$	25,842		$	25,996
Building and leasehold improvements	404,075			416,209
Machinery and equipment	2,145,511			2,025,110
	2,575,428			2,467,315
Less accumulated depreciation	(1,415,397		)	(1,218,507		)
	1,160,031			1,248,808
Construction in progress	99,172			117,705
Total property and equipment, net	$	1,259,203		$	1,366,513

Business Acquisitions

12 Months Ended

Mar. 28, 2020

BUSINESS ACQUISITION DISCLOSURE [Abstract]

BUSINESS ACQUISITIONS

During fiscal 2020, the Company completed the acquisitions of Active-Semi International, Inc. ("Active-Semi"), Cavendish Kinetics Limited ("Cavendish"), Custom MMIC Design Services, Inc. ("Custom MMIC") and Decawave Limited ("Decawave"). The goodwill resulting from these acquisitions is attributed to synergies and other benefits that are expected to be generated from these transactions.

The operating results of these companies, which were not material either individually or in the aggregate for fiscal 2020, have been included in the Company's consolidated financial statements as of their acquisition dates.

Active-Semi International, Inc.

On May 6, 2019, the Company acquired all of the outstanding equity interests of Active-Semi, a private fabless supplier of programmable analog power management solutions, for a total purchase price of $307.9 million. The acquisition expanded the Company's product offerings for existing customers and new customers in power management markets.

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):



Net tangible assets (1)	$	22,876
Intangible assets	158,400
Goodwill	130,802
Deferred tax liability, net	(4,184		)
	$	307,894

(1) Includes cash acquired of $10.0 million.

The more significant intangible assets acquired included developed technology of $76.7 million, customer relationships of $40.9 million and IPRD of $40.6 million.

The fair values of the Active-Semi developed technology and IPRD acquired were determined based on an income approach using the "excess earnings method," which estimated the values of the intangible assets by discounting the future projected earnings of the asset to present value as of the valuation date. The acquired developed technology assets are being amortized on a straight-line basis over their estimated useful lives of 5 to 9 years.

During fiscal 2020, $31.0 million of IPRD assets were completed, transferred to finite-lived intangible assets, and are being amortized over their estimated useful lives of 5 to 7 years. The IPRD remaining as of March 28, 2020 is expected to be completed during fiscal 2021 with remaining costs to complete of less than $2.0 million.

The fair value of Active-Semi customer relationships acquired was determined based on an income approach using the "with and without method," in which the value of the asset is determined by the difference in discounted cash flows of the profitability of the Company "with" the asset and the profitability of the Company "without" the asset. These customer relationships are being amortized on a straight-line basis over their estimated useful lives of 5 years.

The Company will continue to evaluate certain assets, liabilities and tax estimates over the measurement period (up to one year from the acquisition date). Goodwill recognized from the acquisition of Active-Semi is not deductible for income tax purposes.

During fiscal 2020, the Company recorded post-combination compensation expense as well as other acquisition and integration related costs associated with the acquisition of Active-Semi of $25.3 million and $4.2 million in "Other operating expense" and "Cost of goods sold," respectively, in the Consolidated Statement of Operations.

Cavendish Kinetics Limited

As of September 28, 2019, the Company had an investment in preferred shares in Cavendish, a private supplier of high-performance RF microelectromechanical system ("MEMS") technology for antenna tuning applications, with a carrying value of $59.4 million. The Company accounted for this investment as an equity investment without a readily determinable fair value using the measurement alternative in accordance with ASC 321, "Investments–Equity Securities."

On October 4, 2019, the Company acquired the remaining issued and outstanding capital of Cavendish for cash consideration of $198.4 million. The acquisition advances RF MEMS technology for applications across the Company's products and the technology will be transitioned into high-volume manufacturing for mobile devices and other markets.

The purchase of the remaining equity interest in Cavendish was considered to be an acquisition achieved in stages, whereby the previously held equity interest was remeasured at its acquisition-date fair value. The Company determined that the fair value of its previously held equity investment was $102.4 million based on the purchase consideration exchanged to acquire the remaining issued and outstanding capital of Cavendish. This resulted in recognition of a gain of $43.0 million in fiscal 2020, which is recorded in "Other income (expense)" in the Consolidated Statement of Operations.

The purchase price was calculated as follows (in thousands):



Cash consideration paid to Cavendish	$	198,385
Fair value of equity interest previously held by the Company	102,383
Total purchase price	$	300,768

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):



Net tangible assets (1)	$	97
Intangible assets	206,350
Goodwill	100,845
Deferred tax liability, net	(6,524		)
	$	300,768

(1) Includes cash acquired of $1.8 million.

The most significant intangible asset acquired was developed technology of $206.0 million. The fair value of the Cavendish developed technology acquired was determined based on an income approach using the "excess earnings method," which estimated the value of the intangible asset by discounting the future projected earnings of the asset to present value as of the valuation date. This developed technology is being amortized on a straight-line basis over its estimated useful life of 9 years.

The Company will continue to evaluate certain assets, liabilities and tax estimates over the measurement period (up to one year from the October 4, 2019 acquisition date). Goodwill recognized from the acquisition of Cavendish is not deductible for income tax purposes.

During fiscal 2020, the Company recorded post-combination compensation expense as well as other acquisition and integration related costs associated with the acquisition of Cavendish totaling $3.8 million in "Other operating expense" in the Consolidated Statement of Operations.

Custom MMIC Design Services, Inc.

On February 6, 2020, the Company acquired all of the outstanding equity interests of Custom MMIC, a supplier of high-performance gallium arsenide ("GaAs") and gallium nitride ("GaN") monolithic microwave integrated circuits ("MMICs") for defense, aerospace and commercial applications, for a total purchase price of $91.7 million. The acquisition expands the Company's millimeter wave ("mmWave") capabilities for product offerings in defense and commercial markets.

The purchase price was comprised of cash consideration of $86.0 million and contingent consideration of up to $10.0 million which is payable to the sellers in the first quarter of fiscal 2022 if certain revenue targets are achieved over a one-year period from the acquisition date. The estimated fair value of the contingent consideration was $5.7 million at both the acquisition date and at March 28, 2020 (and is included in "Other long-term liabilities" in the Consolidated Balance Sheet). In subsequent reporting periods, the contingent consideration liability will be remeasured at fair value with changes recognized in "Other operating expense."

In addition to the purchase price consideration, an installment agreement was entered into for $15.5 million which is payable to certain key employees of Custom MMIC and is subject to their continued employment over a three-year period from the acquisition date. This amount is being recognized as post-combination compensation expense over the requisite service period.

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):



Net tangible assets (1)	$	4,988
Intangible assets	31,100
Goodwill	55,654
	$	91,742

(1) Includes cash acquired of $2.3 million.

The more significant intangible assets acquired were customer relationships of $26.9 million. The fair value of Custom MMIC customer relationship intangibles acquired was determined based on an income approach using the "excess earnings method," which estimated the values of the intangible assets by discounting the future projected earnings of the asset to present value as of the valuation date. These customer relationships are being amortized on a straight-line basis over their estimated useful lives of 10 years.

The Company will continue to evaluate certain assets, liabilities and tax estimates over the measurement period (up to one year from the acquisition date). All goodwill recognized from the acquisition of Custom MMIC is deductible for income tax purposes.

During fiscal 2020, the Company recorded post-combination compensation expense as well as other acquisition and integration related costs associated with the acquisition of Custom MMIC totaling $9.4 million in "Other operating expense" in the Consolidated Statement of Operations.

Decawave Limited

On February 21, 2020, the Company acquired all of the outstanding equity interests of Decawave, a pioneer in ultra-wide band ("UWB") technology and provider of UWB solutions for mobile, automotive and Internet of Things ("IoT") applications, for a total purchase price of $374.7 million (of which $372.8 million was paid in cash as of year-end). The acquisition expands the Company's product offerings of technology that enables real-time, highly accurate and reliable local area precision-location services.

In addition to the purchase price consideration, the Company agreed to pay employees of Decawave total compensation of $23.1 million, primarily subject to their continued employment. This amount will be recognized as post-combination compensation expense over the period the employees provide the required services. In fiscal 2020, $5.4 million was recorded in "Other operating expense" in the Consolidated Statement of Operations and $8.1 million and $9.6 million was recorded in "Prepaid expenses" and "Other non-current assets", respectively, in the Consolidated Balance Sheet.

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):



Net tangible assets (1)	$	304
Intangible assets	246,060
Goodwill	149,703
Deferred tax liability, net	(21,327		)
	$	374,740

(1) Includes cash acquired of $5.0 million.

The more significant intangible assets acquired included developed technology of $235.0 million and customer relationships of $10.0 million.

The fair value of the Decawave developed technology acquired was determined based on an income approach using the "excess earnings method," which estimated the values of the intangible asset by discounting the future projected

earnings of the asset to present value as of the valuation date. The acquired developed technology asset is being amortized on a straight-line basis over its estimated useful life of 7 years.

The fair value of Decawave customer relationships acquired was determined based on an income approach using the "with and without method," in which the value of the asset is determined by the difference in discounted cash flows of the profitability of the Company "with" the asset and the profitability of the Company "without" the asset. These customer relationships are being amortized on a straight-line basis over their estimated useful lives of 3 years.

The Company will continue to evaluate certain assets, liabilities and tax estimates over the measurement period (up to one year from the acquisition date). Goodwill recognized from the acquisition of Decawave is not deductible for income tax purposes.

During fiscal 2020, the Company recorded post-combination compensation expense of $5.4 million (as discussed above) as well as other acquisition and integration related costs associated with the acquisition of Decawave of $7.0 million in "Other operating expense" in the Consolidated Statement of Operations.

Goodwill and Intangible Assets

12 Months Ended

Mar. 28, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

The changes in the carrying amount of goodwill for fiscal 2020 are as follows (in thousands):



	Mobile Products		Infrastructure and Defense Products		Total
Balance as of March 30, 2019 (1)	$	1,751,503	$	422,386	$	2,173,889
Active-Semi acquisition	—		130,802		130,802
Cavendish acquisition	100,845		—		100,845
Custom MMIC acquisition	—		55,654		55,654
Decawave acquisition	149,703		—		149,703
Effect of changes in foreign currency exchange rates (2)	3,381		—		3,381
Balance as of March 28, 2020 (1)	$	2,005,432	$	608,842	$	2,614,274

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

(2) Represents the impact of foreign currency translation when goodwill is recorded in foreign entities whose functional currency is also their local currency.

Goodwill is allocated to the reporting units that are expected to benefit from the synergies of the business combinations generating the underlying goodwill.

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):



	March 28, 2020				March 30, 2019
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	1,325,472	$	652,400	$	1,246,335	$	960,793
Customer relationships	463,772		346,799		1,272,725		1,161,735
Technology licenses	3,271		2,327		14,704		13,026
Backlog	1,600		267		—		—
Trade names	1,200		283		29,391		29,391
Non-compete agreement	—		—		1,026		1,026
IPRD	9,600		N/A		10,000		N/A
Effect of changes in foreign currency exchange rates (1)	6,064		11		—		—
Total	$	1,810,979	$	1,002,087	$	2,574,181	$	2,165,971

(1) Represents the impact of foreign currency translation when intangibles are recorded in foreign entities whose functional currency is also their local currency.

Total intangible assets amortization expense was $247.3 million, $454.5 million and $539.8 million in fiscal years 2020, 2019 and 2018, respectively.

The following table provides the Company's estimated amortization expense for intangible assets based on current amortization periods for the periods indicated (in thousands):



Fiscal Year	Estimated Amortization Expense
2021	$	248,000
2022	119,000
2023	103,000
2024	90,000
2025	76,000

Investments and Fair Value Measurements

12 Months Ended

Mar. 28, 2020

Investments and Fair Value Measurements [Abstract]

INVESTMENTS AND FAIR VALUE MEASUREMENTS

INVESTMENTS AND FAIR VALUE OF FINANCIAL INSTRUMENTS

Equity Investments Without a Readily Determinable Fair Value

On October 4, 2019, the Company completed its acquisition of the remaining issued and outstanding capital of Cavendish. Prior to the acquisition date, the Company had accounted for its investment in Cavendish as an equity investment without a readily determinable fair value and the investment was classified in "Long-term investments" in the Consolidated Balance Sheets. See Note 5 for disclosures related to the acquisition of Cavendish.

During fiscal 2020, the Company recorded an impairment of $18.3 million on an equity investment without a readily determinable fair value based on recent observable price changes present at the time. This amount is recorded in "Other income (expense)" in the Consolidated Statement of Operations.

Fair Value of Financial Instruments

The fair value of the financial assets and liabilities measured on a recurring basis was determined using the following levels of inputs as of March 28, 2020 and March 30, 2019 (in thousands):



				Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
March 28, 2020
	Assets
		Marketable equity securities		$	459	$	459	$	—	$	—
		Invested funds in deferred compensation plan (1)		19,398		19,398		—		—
			Total assets measured at fair value	$	19,857	$	19,857	$	—	$	—
	Liabilities
		Deferred compensation plan obligation (1)		$	19,398	$	19,398	$	—	$	—
		Contingent earn-out liability (2)		5,700		—		—		5,700
			Total liabilities measured at fair value	$	25,098	$	19,398	$	—	$	5,700

March 30, 2019
	Assets
		Money market funds		$	13	$	13	$	—	$	—
		Marketable equity securities		901		901		—		—
		Auction rate securities (3)		1,950		—		1,950		—
		Invested funds in deferred compensation plan (1)		18,737		18,737		—		—
			Total assets measured at fair value	$	21,601	$	19,651	$	1,950	$	—
	Liabilities
		Deferred compensation plan obligation (1)		$	18,737	$	18,737	$	—	$	—
			Total liabilities measured at fair value	$	18,737	$	18,737	$	—	$	—

(1) The Company's non-qualified deferred compensation plan provides eligible employees and members of the Board of Directors with the opportunity to defer a specified percentage of their cash compensation. The Company includes the assets deferred by the participants in the "Other current assets" and "Other non-current assets" line items of its Consolidated Balance Sheets and the Company's obligation to deliver the deferred compensation in the "Other current liabilities" and "Other long-term liabilities" line items of its Consolidated Balance Sheets.

(2) The Company recorded a contingent earn-out liability in conjunction with a recent acquisition (see Note 5 for disclosures related to acquisitions). The fair value of this liability was estimated using an option pricing model.

(3) The Company's Level 2 auction rate securities were debt instruments with interest rates that reset through periodic short-term auctions and valued based on quoted prices for identical or similar instruments in markets that were not active. The Company sold its auction rate securities at par value during fiscal 2020.

Leases

12 Months Ended

Mar. 28, 2020

Leases [Abstract]

Leases

LEASES

Operating Leases

The Company leases certain of its corporate, manufacturing and other facilities from multiple third-party real estate developers. The Company also leases various machinery and office equipment. These operating leases expire at various dates through 2036, and some of these leases have renewal options, with the longest ranging up to two, ten-year periods.

Operating leases as of March 28, 2020 are classified as follows (in thousands):



Other non-current assets	$	65,107

Other current liabilities	$	15,917
Other long-term liabilities	$	58,077

Details of operating leases for fiscal 2020 are as follows (in thousands):



Operating lease expense	$	15,184
Short-term lease expense	$	6,878
Variable lease expense	$	3,098

Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	16,504

Operating lease assets obtained in exchange for new lease liabilities	$	13,201

Weighted-average remaining lease term (years)	7.8
Weighted-average discount rate	4.06		%

The aggregate future lease payments for operating leases as of March 28, 2020 are as follows (in thousands):



2021	$	21,586
2022	14,201
2023	9,690
2024	7,449
2025	6,006
Thereafter	27,194
Total lease payments	86,126
Less imputed interest	(12,132		)
Present value of lease liabilities	$	73,994

Finance Lease

In fiscal 2018, the Company entered into a finance lease for a facility in Beijing, China that will allow the Company to consolidate several leased facilities as well as provide additional manufacturing space. The lease term is expected to commence in fiscal 2021 and therefore is not recorded on the Consolidated Balance Sheets as of March 28, 2020 and March 30, 2019. The lease has an initial term of five years and includes multiple renewal options, with the maximum lease term not to exceed 30 years. The total amount expected to be paid over the lease term is $56.2 million.

Prior Fiscal Year Disclosures

As previously disclosed in the Company's Annual Report on Form 10-K for the fiscal year ended March 30, 2019 and under the previous lease accounting standard, the aggregate future non-cancelable minimum lease payments of the Company's operating leases as of March 30, 2019 were as follows (in thousands):



2020	$	22,207
2021	13,382
2022	10,331
2023	8,224
2024	7,139
Thereafter	31,598
Total minimum payments	$	92,881

Rent expense under operating leases, covering facilities and equipment, was approximately $19.3 million and $16.3 million for fiscal years 2019 and 2018, respectively, prior to the adoption of the new lease accounting standard.

Debt

12 Months Ended

Mar. 28, 2020

Debt Disclosure [Abstract]

DEBT

Debt as of March 28, 2020 and March 30, 2019 is as follows (in thousands):



	March 28, 2020			March 30, 2019
Term loan	$	100,000		$	—
7.00% senior notes due 2025	23,404			23,404
5.50% senior notes due 2026	900,000			900,000
4.375% senior notes due 2029	550,000			—
Finance leases	2,252			1,745
Less unamortized premium and issuance costs, net	(1,532		)	(4,134		)
Less current portion of long-term debt	(6,893		)	(80		)
Total long-term debt	$	1,567,231		$	920,935

Credit Agreement

On December 5, 2017, the Company and the Guarantors entered into a five-year unsecured senior credit facility pursuant to a credit agreement with Bank of America, N.A., as administrative agent (in such capacity, the "Administrative Agent"), swing line lender and L/C issuer, and a syndicate of lenders (the "Credit Agreement"). The Credit Agreement included a senior delayed draw term loan of up to $400.0 million (the "Term Loan") and a $300.0 million senior revolving line of credit (the "Revolving Facility"). In addition, the Company may request one or more additional tranches of term loans or increases in the Revolving Facility, up to an aggregate of $300.0 million and subject to securing additional funding commitments from the existing or new lenders (the "Incremental Facility", and collectively with the Term Loan and the Revolving Facility, the "Credit Facility"). On the closing date, $100.0 million of the Term Loan was funded (and was subsequently repaid in March 2018). On June 17, 2019, the Company drew $100.0 million of the Term Loan. The delayed draw availability period for the remaining $200.0 million of the Term Loan expired on December 31, 2019. The Revolving Facility includes a $25.0 million sublimit for the issuance of standby letters of credit and a $10.0 million sublimit for swing line loans. The Credit Facility is available to finance working capital, capital expenditures and other corporate purposes. Outstanding amounts are due in full on the maturity date of December 5, 2022 (with amounts borrowed under the swingline option due in full no later than ten business days after such loan is made), subject to scheduled amortization of the Term Loan principal as set forth in the Credit Agreement prior to the maturity date. During fiscal 2020, there were no borrowings under the Revolving Facility. Interest paid on the Term Loan during fiscal 2020 was $2.4 million.

At the Company’s option, loans under the Credit Agreement bear interest at (i) the Applicable Rate (as defined in the Credit Agreement) plus the Eurodollar Rate (as defined in the Credit Agreement) or (ii) the Applicable Rate plus a rate equal to the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate of the Administrative Agent, or

(c) the Eurodollar Base Rate plus 1.0% (the "Base Rate"). All swingline loans will bear interest at a rate equal to the Applicable Rate plus the Base Rate. The Eurodollar Rate is the rate per annum equal to the reserve adjusted London Interbank Offered Rate (or a comparable or successor rate), for dollar deposits for interest periods of one, two, three, six or twelve months, as selected by the Company. The Applicable Rate for Eurodollar Rate loans ranges from 1.125% per annum to 1.375% per annum. The Applicable Rate for Base Rate loans ranges from 0.125% per annum to 0.375% per annum. Interest for Eurodollar Rate loans will be payable at the end of each applicable interest period or at three-month intervals, if such interest period exceeds three months. Interest for Base Rate loans will be payable quarterly in arrears. The Company will pay a letter of credit fee equal to the Applicable Rate multiplied by the daily amount available to be drawn under any letter of credit, a fronting fee, and any customary documentary and processing charges for any letter of credit issued under the Credit Agreement.

The Credit Agreement contains various conditions, covenants and representations with which the Company must comply in order to borrow funds and to avoid an event of default, including the following financial covenants that the Company must maintain: (i) a consolidated leverage ratio not to exceed 3.0 to 1.0 as of the end of any fiscal quarter of the Company, provided that in connection with a permitted acquisition in excess of $300.0 million, the Company's maximum consolidated leverage ratio may increase on two occasions during the term of the Credit Facility to 3.5 to 1.0 for four consecutive fiscal quarters, beginning with the fiscal quarter in which such acquisition occurs and (ii) an interest coverage ratio not to be less than 3.0 to 1.0 as of the end of any fiscal quarter of the Company. As of March 28, 2020, the Company was in compliance with these covenants.

The annual maturities of the Term Loan as of March 28, 2020 are as follows (in thousands):



Fiscal Year	Maturities
2021	$	6,250
2022	5,000
2023	88,750
	$	100,000

Senior Notes due 2023 and 2025

On November 19, 2015, the Company issued $450.0 million aggregate principal amount of its 6.75% senior notes due December 1, 2023 (the "2023 Notes") and $550.0 million aggregate principal amount of its 7.00% senior notes due December 1, 2025 (the "2025 Notes"). The 2023 Notes were, and the 2025 Notes are, senior unsecured obligations of the Company and guaranteed, jointly and severally, by certain of the Company's U.S. subsidiaries (the "Guarantors"). The 2023 Notes and the 2025 Notes were issued pursuant to an indenture dated as of November 19, 2015 (the "2015 Indenture"), by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee. The 2015 Indenture contains customary events of default, including payment default, failure to provide certain notices and certain provisions related to bankruptcy events.

In fiscal years 2018 and 2019, the Company retired all of the issued and outstanding 2023 Notes and $526.6 million of the 2025 Notes. During fiscal 2019, the Company recognized a loss on debt extinguishment of $90.2 million (related to the retirements of the 2023 Notes and the 2025 Notes) as "Other expense" in the Company’s Consolidated Statement of Operations. As of March 28, 2020, an aggregate principal amount of $23.4 million of the 2025 Notes remained outstanding.

At any time prior to December 1, 2020, the Company may redeem all or part of the 2025 Notes, at a redemption price equal to their principal amount, plus a "make-whole" premium as of the redemption date, and accrued and unpaid interest. In addition, at any time on or after December 1, 2020, the Company may redeem the 2025 Notes, in whole or in part, at the redemption prices specified in the 2015 Indenture, plus accrued and unpaid interest.

With respect to the 2023 Notes, interest was payable on June 1 and December 1 of each year at a rate of 6.75% per annum, and with respect to the 2025 Notes, interest is payable on June 1 and December 1 of each year at a rate of 7.00% per annum. Interest paid on the 2025 Notes during fiscal 2020 was $1.6 million and the total interest paid on the 2023 Notes and the 2025 Notes during fiscal years 2019 and 2018 was $46.5 million and $68.9 million, respectively.

Senior Notes due 2026

On July 16, 2018, the Company issued $500.0 million aggregate principal amount of its 5.50% senior notes due 2026 (the "Initial 2026 Notes"). On August 28, 2018 and March 5, 2019, the Company issued an additional $130.0 million and $270.0 million, respectively, aggregate principal amount of such notes (together, the "Additional 2026 Notes", and together with the Initial 2026 Notes, the "2026 Notes"). The 2026 Notes will mature on July 15, 2026, unless earlier redeemed in accordance with their terms. The 2026 Notes are senior unsecured obligations of the Company and are initially guaranteed, jointly and severally, by the Guarantors.

The Initial 2026 Notes were issued pursuant to an indenture, dated as of July 16, 2018, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2026 Notes were issued pursuant to supplemental indentures, dated as of August 28, 2018 and March 5, 2019, respectively (such indenture and supplemental indentures, collectively, the "2018 Indenture"). The 2018 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events and also contains customary negative covenants.

At any time prior to July 15, 2021, the Company may redeem all or part of the 2026 Notes, at a redemption price equal to their principal amount, plus a “make-whole” premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to July 15, 2021, the Company may redeem up to 35% of the original aggregate principal amount of the 2026 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 105.50% of the principal amount of the 2026 Notes redeemed, plus accrued and unpaid interest. Furthermore, at any time on or after July 15, 2021, the Company may redeem the 2026 Notes, in whole or in part, at the redemption prices specified in the 2018 Indenture, plus accrued and unpaid interest.

In connection with the offering of the 2026 Notes, the Company agreed to provide the holders of the 2026 Notes with an opportunity to exchange the 2026 Notes for registered notes having terms substantially identical to the 2026 Notes. On June 25, 2019, the Company completed the exchange offer, in which all of the privately placed 2026 Notes were exchanged for new notes that have been registered under the Securities Act of 1933, as amended.

Interest is payable on the 2026 Notes on January 15 and July 15 of each year at a rate of 5.50% per annum. Interest paid on the 2026 Notes during fiscal years 2020 and 2019 was $49.5 million and $17.2 million, respectively.

Senior Notes due 2029

On September 30, 2019, the Company issued $350.0 million aggregate principal amount of its 4.375% senior notes due 2029 (the "Initial 2029 Notes"). On December 20, 2019, the Company issued an additional $200.0 million aggregate principal amount of such notes (the "Additional 2029 Notes", and together with the Initial 2029 Notes, the "2029 Notes"). The 2029 Notes will mature on October 15, 2029, unless earlier redeemed in accordance with their terms. The 2029 Notes are senior unsecured obligations of the Company and are initially guaranteed, jointly and severally, by the Guarantors.

The Initial 2029 Notes were issued pursuant to an indenture, dated as of September 30, 2019, by and among the Company, the Guarantors and MUFG Union Bank, N.A., as trustee, and the Additional 2029 Notes were issued pursuant to a supplemental indenture, dated as of December 20, 2019 (such indenture and supplemental indenture, together, the "2019 Indenture"). The 2019 Indenture contains customary events of default, including payment default, exchange default, failure to provide certain notices thereunder and certain provisions related to bankruptcy events and also contains customary negative covenants.

At any time prior to October 15, 2024, the Company may redeem all or part of the 2029 Notes, at a redemption price equal to their principal amount, plus a "make-whole" premium as of the redemption date, and accrued and unpaid interest. In addition, at any time prior to October 15, 2024, the Company may redeem up to 35% of the original aggregate principal amount of the 2029 Notes with the proceeds of one or more equity offerings, at a redemption price equal to 104.375%, plus accrued and unpaid interest. Furthermore, at any time on or after October 15, 2024, the Company may redeem the 2029 Notes, in whole or in part, at the redemption prices specified in the 2019 Indenture, plus accrued and unpaid interest.

The 2029 Notes have not been registered under the Securities Act, or any state securities laws, and, unless so registered, may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

In connection with the offering of the Initial 2029 Notes, the Company entered into a registration rights agreement, dated as of September 30, 2019, by and among the Company and the Guarantors, on the one hand, and BofA Securities, Inc., as representative of the initial purchasers of the Initial 2029 Notes, on the other hand, and a substantially similar agreement, dated as of December 20, 2019, with respect to the Additional 2029 Notes (together, the "Registration Rights Agreements").

Under the Registration Rights Agreements, the Company and the Guarantors have agreed to use their commercially reasonable efforts to (i) file with the SEC a registration statement (the "Exchange Offer Registration Statement") relating to the registered exchange offer (the "Exchange Offer") to exchange the 2029 Notes for a new series of the Company’s exchange notes having terms substantially identical in all material respects to, and in the same aggregate principal amount as, the 2029 Notes; (ii) cause the Exchange Offer Registration Statement to be declared effective by the SEC; and (iii) cause the Exchange Offer to be consummated no later than the 360th day after September 30, 2019 (or if such 360th day is not a business day, the next succeeding business day). The Company and the Guarantors have also agreed to use their commercially reasonable efforts to cause the Exchange Offer Registration Statement to be effective continuously and keep the Exchange Offer open for a period of not less than the minimum period required under applicable federal and state securities laws to consummate the Exchange Offer.

Under certain circumstances, the Company and the Guarantors have agreed to use their commercially reasonable efforts to (i) file a shelf registration statement relating to the resale of the 2029 Notes as promptly as practicable, and (ii) cause the shelf registration statement to be declared effective by the SEC as promptly as practicable. The Company and the Guarantors have also agreed to use their commercially reasonable efforts to keep the shelf registration statement continuously effective until one year after its effective date (or such shorter period that will terminate when all the 2029 Notes covered thereby have been sold pursuant thereto).

If the Company fails to meet any of these targets, the annual interest rate on the 2029 Notes will increase by 0.25% during the 90-day period following the default and will increase by an additional 0.25% for each subsequent 90-day period during which the default continues, up to a maximum additional interest rate of 1.00% per year. If the Company cures the default, the interest rate on the 2029 Notes will revert to the original level.

Interest is payable on the 2029 Notes on April 15 and October 15 of each year at a rate of 4.375% per annum, commencing April 15, 2020.

Fair Value of Long-Term Debt

The Company's long-term debt is carried at amortized cost and is measured at fair value quarterly for disclosure purposes. The estimated fair value of the 2025 Notes as of March 28, 2020 and March 30, 2019 was $23.9 million and $25.8 million, respectively (compared to a carrying value of $23.4 million). The estimated fair value of the 2026 Notes as of March 28, 2020 and March 30, 2019 was $962.8 million and $929.3 million, respectively (compared to a carrying value of $900.0 million). The estimated fair value of the 2029 Notes as of March 28, 2020 was $489.5 million (compared to a carrying value of $550.0 million). The Company considers its long-term debt to be Level 2 in the fair value hierarchy. Fair values are estimated based on quoted market prices for identical or similar instruments. The 2025 Notes, the 2026 Notes and the 2029 Notes trade over the counter, and their fair values were estimated based upon the value of their last trade at the end of the period.

Since the Term Loan carries a variable interest rate set at current market rates, the fair value of the Term Loan approximated book value as of March 28, 2020.

Interest Expense

During fiscal 2020, the Company recognized $66.0 million of interest expense primarily related to the 2026 Notes and the 2029 Notes, which was partially offset by $5.6 million of interest capitalized to property and equipment. During fiscal 2019, the Company recognized $52.8 million of interest expense primarily related to the 2023 Notes, the 2025 Notes and the 2026 Notes, which was partially offset by $8.8 million of interest capitalized to property and

equipment. During fiscal 2018, the Company recognized $73.2 million of interest expense, primarily related to the 2023 Notes and the 2025 Notes, which was partially offset by $13.6 million of interest capitalized to property and equipment.

Retirement Benefit Plans	12 Months Ended
Retirement Benefit Plans	Mar. 28, 2020
Retirement Benefits [Abstract]
RETIREMENT BENEFIT PLANS	RETIREMENT BENEFIT PLANS Defined Contribution Plans The Company offers tax-beneficial retirement contribution plans to eligible employees in the U.S. and certain other countries. Eligible employees in certain countries outside of the U.S. are eligible to participate in stakeholder or national pension plans with differing eligibility and contributory requirements based on local and national regulations. U.S. employees are eligible to participate in the Company's fully qualified 401(k) plan 30 days after their date of hire. An employee may invest pretax earnings in the 401(k) plan up to the maximum legal limits (as defined by Federal regulations). Employer contributions to the 401(k) plan are made at the discretion of the Company’s Board of Directors. Employees are immediately vested in their own contributions as well as employer matching contributions. In total, the Company contributed $14.4 million, $14.0 million and $14.0 million to its domestic and foreign defined contribution plans during fiscal years 2020, 2019 and 2018, respectively. Defined Benefit Pension Plans The Company maintains two qualified defined benefit pension plans for its subsidiaries located in Germany. One of the plans is funded through a self-paid reinsurance program with assets valued at $3.6 million as of March 28, 2020 and March 30, 2019 (included in "Other non-current assets" in the Consolidated Balance Sheets). The pension benefit obligations of both plans were $12.3 million and $12.9 million as of March 28, 2020 and March 30, 2019, respectively, which is included in "Accrued liabilities" and "Other long-term liabilities" in the Consolidated Balance Sheets. The assumptions used in calculating the benefit obligations for the plans are dependent on the local economic conditions and were measured as of March 28, 2020 and March 30, 2019. The net periodic benefit costs were approximately $0.6 million, $0.5 million and $0.7 million for fiscal years 2020, 2019 and 2018, respectively. Non-Qualified Deferred Compensation Plan Certain employees and members of the Board of Directors are eligible to participate in the Company's Non-Qualified Deferred Compensation Plan ("NQDC Plan"). The NQDC Plan provides eligible participants the opportunity to defer and invest a specified percentage of their cash compensation. The NQDC Plan is a non-qualified plan that is maintained in a rabbi trust. The amount of compensation to be deferred by each participant is based on their own elections and is adjusted for any investment changes that the participant directs. The deferred compensation obligation and the fair value of the investments held in the rabbi trust were $19.4 million and $18.7 million as of March 28, 2020 and March 30, 2019, respectively. The current portion of the deferred compensation obligation and fair value of the assets held in the rabbi trust were $0.9 million and $1.1 million as of March 28, 2020 and March 30, 2019, respectively, and are included in "Other current assets" and "Accrued liabilities" in the Consolidated Balance Sheets. The non-current portion of the deferred compensation obligation and fair value of the assets held in the rabbi trust were $18.5 million and $17.6 million as of March 28, 2020 and March 30, 2019, respectively, and are included in "Other non-current assets" and "Other long-term liabilities" in the Consolidated Balance Sheets.

Commitments and Contingent Liabilities	12 Months Ended
Commitments and Contingent Liabilities	Mar. 28, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	COMMITMENTS AND CONTINGENT LIABILITIES Purchase Commitments The Company's purchase commitments total approximately $318.3 million, a substantial majority of which will be due within the next 12 months. Purchase commitments include payments due for materials and manufacturing services and commitments for the purchase of property and equipment. Lease Commitments See Note 8 for disclosures related to lease commitments. Legal Matters The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and that it can reasonably estimate the amount of the loss. The Company reviews these accruals and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the Company's views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company's accrued liabilities would be recorded in the period in which such determination is made. The Company is involved in various legal proceedings and claims that have arisen in the ordinary course of its business that have not been fully adjudicated. These actions, when finally concluded and determined, will not, in the opinion of management, have a material adverse effect upon the Company’s consolidated financial position or results of operations.

Restructuring

12 Months Ended

Mar. 28, 2020

Restructuring and Related Activities [Abstract]

RESTRUCTURING

During fiscal years 2020, 2019 and 2018, the Company recorded restructuring related charges totaling approximately $47.9 million, $50.7 million and $67.7 million, respectively, related primarily to (1) fiscal 2019 actions to reduce operating expenses and improve manufacturing cost structure, (2) fiscal 2018 actions to improve operating efficiencies, and (3) actions resulting from the Business Combination.

During fiscal 2019, the Company initiated restructuring actions to reduce operating expenses and improve its manufacturing cost structure, including the phased closure of a wafer fabrication facility in Florida and idling production at a wafer fabrication facility in Texas. As a result of these actions, the Company recorded cumulative restructuring related charges of $92.0 million during fiscal years 2020 and 2019, including accelerated depreciation of $47.4 million (to reflect changes in estimated useful lives of certain property and equipment), impairment charges of $15.9 million (to adjust the carrying value of certain property and equipment to reflect its fair value), employee termination benefits of $13.7 million and other exit costs of $15.0 million. The Company expects to record additional expenses of approximately $1.0 million for employee termination benefits and other exit costs as a result of these actions.

The fair value of the real property was derived based upon a market approach with substantial input from market participants, including brokers, investors, developers and appraisers. The fair value of the personal property was determined using a market approach based upon quoted market prices from auction data for comparable assets. Factors such as age, condition, capacity and manufacturer were considered to adjust the auction price and determine an orderly liquidation value of the personal property assets. The significant inputs related to valuing these assets are classified as Level 2 in the fair value measurement hierarchy.

During fiscal 2018, the Company initiated restructuring actions to improve operating efficiencies. As a result of these actions (which are substantially complete), in fiscal years 2020, 2019 and 2018, the Company recorded cumulative restructuring related charges of $46.3 million, $23.5 million and $0.2 million for asset impairments, employee termination benefits and other exit costs, respectively.

Primarily as a result of the Business Combination (see Note 1), during fiscal years 2020, 2019 and 2018, the Company recorded restructuring related charges (including employee termination benefits and ongoing expenses related to exited leased facilities) of approximately $0.3 million, $1.3 million and $2.7 million, respectively.

The following table summarizes the restructuring charges primarily resulting from these restructuring events (in thousands):



	Fiscal 2020
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	6,289	$	6,289
Contract termination and other associated costs	8,365		7,154		15,519
Accelerated depreciation	26,061		—		26,061
Total	$	34,426	$	13,443	$	47,869

	Fiscal 2019
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	12,826	$	12,826
Contract termination and other associated costs	—		641		641
Asset impairment and accelerated depreciation	21,346		15,901		37,247
Total	$	21,346	$	29,368	$	50,714

	Fiscal 2018
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	19,232	$	19,232
Contract termination and other associated costs	—		2,174		2,174
Asset impairment	—		46,315		46,315
Total	$	—	$	67,721	$	67,721

The following table summarizes the activity related to the Company's restructuring liabilities for fiscal years 2019 and 2020 (in thousands):



	One-Time Employee Termination Benefits			Asset Impairment and Accelerated Depreciation			Contract Termination and Other Associated Costs			Total
Accrued restructuring balance as of March 31, 2018	$	6,130		$	—		$	2,557		$	8,687
Costs incurred and charged to expense	12,826			37,247			641			50,714
Cash payments	(11,968		)	—			(1,572		)	(13,540		)
Non-cash activity	—			(37,247		)	—			(37,247		)
Accrued restructuring balance as of March 30, 2019	$	6,988		$	—		$	1,626		$	8,614
Costs incurred and charged to expense	6,289			26,061			15,519			47,869
Transfer to right-of-use asset	—			—			(1,248		)	(1,248		)
Cash payments	(11,549		)	—			(7,262		)	(18,811		)
Non-cash activity	—			(26,061		)	(8,365		)	(34,426		)
Accrued restructuring balance as of March 28, 2020	$	1,728		$	—		$	270		$	1,998

Income Taxes

12 Months Ended

Mar. 28, 2020

Income Tax Disclosure [Abstract]

INCOME TAXES

Income (loss) before income taxes consists of the following components (in thousands):



	Fiscal Year
	2020			2019			2018
United States	$	(226,005	)	$	(297,975	)	$	(151,083	)
Foreign	621,094			389,767			168,228
Total	$	395,089		$	91,792		$	17,145

The components of the income tax provision are as follows (in thousands):



	Fiscal Year
	2020			2019			2018
Current (expense) benefit:
Federal	$	(6,705	)	$	17,222		$	(28,168	)
State	(93		)	209			(229		)
Foreign	(65,065		)	(46,267		)	(61,284		)
	(71,863		)	(28,836		)	(89,681		)
Deferred benefit (expense):
Federal	$	7,826		$	55,833		$	11,817
State	4,603			946			253
Foreign	(1,330		)	13,390			20,178
	11,099			70,169			32,248
Total	$	(60,764	)	$	41,333		$	(57,433	)

On December 22, 2017, the Tax Cuts and Jobs Act ("Tax Act") was signed into law in the U.S., lowering the U.S. corporate income tax rate to 21% from 35%, instituting a one-time transition tax on unrepatriated foreign earnings (the "Transitional Repatriation Tax"), and implementing a territorial tax system. During fiscal 2018, the Company recorded a net provisional tax expense of $77.3 million for the estimated effects of the Tax Act. In accordance with Staff Accounting Bulletin No. 118, the Company completed its analysis of the impact of the Tax Act during fiscal 2019 and recorded a net discrete income tax benefit adjustment of $17.0 million to the prior year provisional estimates. The Global Intangible Low-Taxed Income ("GILTI") provisions became effective for the Company in fiscal 2019, at which time the Company elected to treat taxes due on future GILTI inclusions in U.S. taxable income as current-period expense (the "period cost method").

On March 27, 2020, the U.S. enacted the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act") to help provide relief as a result of the COVID-19 outbreak. Similarly, governments around the world have enacted or implemented various forms of tax relief to assist with the economic disruption in the wake of COVID-19. The measures vary by jurisdiction, but often include the ability to delay certain income tax payments. As of March 28, 2020, the COVID-19 relief measures did not have a material impact on the Company's effective tax rate or other income tax accounts.

A reconciliation of the provision for income taxes to income tax expense computed by applying the statutory federal income tax rate to pre-tax income (loss) for fiscal years 2020, 2019 and 2018 is as follows (dollars in thousands):



	Fiscal Year
	2020					2019					2018
	Amount			Percentage		Amount			Percentage		Amount			Percentage
Income tax expense at statutory federal rate	$	(82,969	)	21.0	%	$	(19,276	)	21.0	%	$	(5,407	)	31.5	%
(Increase) decrease resulting from:
State benefit, net of federal expense	2,605			(0.7	)	710			(0.8	)	474			(2.8	)
Tax credits	64,017			(16.2	)	69,856			(76.1	)	38,054			(221.9	)
Effect of changes in income tax rate applied to net deferred tax assets	(2,269		)	0.6		12,972			(14.1	)	39,168			(228.4	)
Foreign tax rate difference	75,247			(19.0	)	41,672			(45.4	)	21,829			(127.3	)
Foreign permanent differences and related items	(5,446		)	1.4		6,825			(7.4	)	(2,598		)	15.2
Change in valuation allowance	6,438			(1.6	)	2,353			(2.6	)	(1,632		)	9.5
Expiration of state attributes	(5,165		)	1.3		—			—		—			—
Stock-based compensation	(1,707		)	0.4		(7,694		)	8.4		9,924			(57.9	)
Tax reserve adjustments	(13,973		)	3.5		5,213			(5.7	)	(29,188		)	170.2
U.S. tax on foreign earnings, including GILTI	(81,916		)	20.8		(76,215		)	83.0		(5,098		)	29.7
U.S. Transitional Repatriation Tax	—			—		1,897			(2.1	)	(116,419		)	679.0
Intra-entity transfer	—			—		3,935			(4.3	)	(6,873		)	40.1
Permanent reinvestment assertion	(6,814		)	1.7		—			—		—			—
Acquisition related adjustments	(7,257		)	1.8		—			—		—			—
Other income tax (expense) benefit	(1,555		)	0.4		(915		)	1.1		333			(1.9	)
	$	(60,764	)	15.4	%	$	41,333		(45.0	)%	$	(57,433	)	335.0	%

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the basis used for income tax purposes. The deferred income tax assets and liabilities are measured in each taxing jurisdiction using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

Significant components of the Company’s net deferred income taxes are as follows (in thousands):



	March 28, 2020			March 30, 2019
Deferred income tax assets:
Inventory reserve	$	10,114		$	8,588
Equity compensation	18,817			27,380
Net operating loss carry-forwards	71,928			13,744
Research and other credits	106,958			95,640
Employee benefits	12,606			13,070
Lease liabilities	16,456			—
Other deferred assets	3,559			19,457
Total deferred income tax assets	240,438			177,879
Valuation allowance	(35,280		)	(40,433		)
Total deferred income tax assets, net of valuation allowance	$	205,158		$	137,446

Deferred income tax liabilities:
Amortization and purchase accounting basis difference	$	(107,517	)	$	(45,665	)
Accumulated depreciation/basis difference	(59,356		)	(62,097		)
Accrued tax on unremitted foreign earnings	(15,521		)	—
Right-of-use assets	(14,400		)	—
Other deferred liabilities	(1,955		)	—
Total deferred income tax liabilities	(198,749		)	(107,762		)
Net deferred income tax asset	$	6,409		$	29,684

Amounts included in the Consolidated Balance Sheets:
Other non-current assets	$	45,754		$	30,017
Other long-term liabilities	(39,345		)	(333		)
Net deferred income tax asset	$	6,409		$	29,684

The Company has recorded a valuation allowance against certain U.S. and foreign deferred tax assets as of March 28, 2020 and March 30, 2019. These valuation allowances were established based upon management's opinion that it is more likely than not (a likelihood of more than 50 percent) that the benefit of these deferred tax assets may not be realized.

The valuation allowance against deferred tax assets decreased by approximately $5.2 million in fiscal 2020. The decrease was comprised of a $7.9 million decrease in the valuation allowance against state deferred tax assets for net operating losses and credits and a $2.7 million increase for the valuation allowance against deferred tax assets for net operating losses at foreign subsidiaries, $2.1 million of which was due to purchase accounting related adjustments. At the end of fiscal 2020, a $3.8 million valuation allowance remained against deferred assets at foreign subsidiaries and a $31.5 million valuation allowance remained against state deferred tax assets.

The valuation allowance against deferred tax assets decreased by $2.4 million in fiscal 2019. The decrease was comprised of a $1.5 million decrease in the valuation allowance against state deferred tax assets for net operating losses and tax credits and a $0.9 million decrease for the valuation allowance against deferred tax assets for net operating losses at foreign subsidiaries. At the end of fiscal 2019, a $1.1 million valuation allowance remained against deferred tax assets at foreign subsidiaries and a $39.3 million valuation allowance remained against state deferred tax assets.

The valuation allowance against deferred tax assets increased by $9.7 million in fiscal 2018. The increase was comprised of a $6.8 million increase resulting from tax rate changes, primarily the federal rate enacted in the Tax Act, a $1.9 million increase in the valuation allowance against state deferred tax assets for net operating losses and tax credits, a $1.0 million increase for the valuation allowance against deferred tax assets for net operating losses at foreign subsidiaries and a $0.5 million increase in the valuation allowance for state tax credits due to the adoption of

ASU 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting." It was partially offset by a $0.5 million decrease in valuation allowance for federal deferred tax assets for foreign tax credits. At the end of fiscal 2018, a $2.0 million valuation allowance remained against deferred tax assets at foreign subsidiaries and a $40.8 million valuation allowance remained against domestic deferred tax assets.

As of March 28, 2020, the Company had federal loss carryovers of approximately $190.4 million that expire in fiscal years 2021 to 2040 if unused and state losses of approximately $281.1 million that expire in fiscal years 2021 to 2040 if unused. Federal research credits of $143.0 million, and state credits of $64.1 million may expire in fiscal years 2030 to 2040 and 2021 to 2040, respectively. The Company had foreign losses of $107.5 million, some of which may expire in fiscal years 2021 to 2030 if unused. Included in the amounts above are $397.5 million of federal, state and foreign losses and $7.5 million of tax credits related to acquisitions in the current year. The utilization of acquired domestic assets is subject to certain annual limitations as required under Section 382 of the Internal Revenue Code of 1986, as amended (the "Code") and similar state income tax provisions.

The Company has continued to expand its operations and increase its investments in numerous international jurisdictions. These activities expose the Company to taxation in multiple foreign jurisdictions. Management has concluded that it can no longer support an assertion that certain earnings which have been subject to U.S. federal taxation at its foreign subsidiaries are permanently reinvested. During the second quarter of fiscal 2020, the Company updated forecasts of cash balances and cash flow outside the U.S. and began to implement a more centralized approach to cash management. As a result, the Company recorded $6.8 million of tax expense during fiscal 2020. In the third quarter of fiscal 2018, the Company had previously released its permanent reinvestment assertion on its largest operating subsidiary in Singapore, Qorvo International Pte. Ltd. The remainder of the Company's foreign earnings and historic investments will continue to be permanently reinvested to fund working capital requirements and operations abroad. It is not practical to estimate the additional tax that would be incurred, if any, if the remainder of the permanently reinvested earnings were repatriated.

The Company has foreign subsidiaries with tax holiday agreements in Singapore and Costa Rica. These tax holiday agreements have varying rates and expire in December 2021 and December 2027, respectively. Incentives from these countries are subject to the Company meeting certain employment and investment requirements. The Company does not expect that the Singapore legislation enacted in February 2017, which will exclude from the Company's existing Development and Expansion Incentive grant the benefit of the reduced tax rate for intellectual property income earned after June 30, 2021, will have an impact on the Company. Income tax expense decreased by $62.9 million (an impact of approximately $0.54 and $0.53 per basic and diluted share, respectively) in fiscal 2020 and $34.6 million (an impact of approximately $0.28 and $0.27 per basic and diluted share, respectively) in fiscal 2019 as a result of these agreements.

The Company’s gross unrecognized tax benefits totaled $119.2 million as of March 28, 2020, $103.2 million as of March 30, 2019, and $122.8 million as of March 31, 2018. Of these amounts, $114.8 million (net of federal benefit of state taxes), $99.1 million (net of federal benefit of state taxes) and $118.7 million (net of federal benefit of state taxes) as of March 28, 2020, March 30, 2019, and March 31, 2018, respectively, represent the amounts of unrecognized tax benefits that, if recognized, would impact the effective tax rate in each of the fiscal years.

The Company’s gross unrecognized tax benefits increased from $103.2 million as of March 30, 2019 to $119.2 million as of March 28, 2020, primarily due to increases related to current year tax positions, the effect of provision-to-return adjustments on prior year positions, and increases related to business combinations recognized as part of purchase accounting.

A reconciliation of fiscal 2018 through fiscal 2020 beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):



	Fiscal Year
	2020			2019			2018
Beginning balance	$	103,178		$	122,823		$	90,615
Additions based on positions related to current year	10,357			7,193			26,431
Additions for tax positions in prior years	6,484			8,369			5,844
Reductions for tax positions in prior years	(69		)	(24,932		)	(67		)
Expiration of statute of limitations	(728		)	(6,972		)	—
Settlements	—			(3,303		)	—
Ending balance	$	119,222		$	103,178		$	122,823

It is the Company’s policy to recognize interest and penalties related to uncertain tax positions as a component of income tax expense. During fiscal years 2020, 2019 and 2018, the Company recognized $0.7 million, $(0.2) million and $(2.5) million, respectively, of interest and penalties related to uncertain tax positions. Accrued interest and penalties related to unrecognized tax benefits totaled $5.4 million, $4.4 million and $4.6 million as of March 28, 2020, March 30, 2019 and March 31, 2018, respectively.

The unrecognized tax benefits of $119.2 million and accrued interest and penalties of $5.4 million at the end of fiscal 2020 are recorded on the Consolidated Balance Sheet as a $19.4 million other long-term liability, with the balance reducing the carrying value of the gross deferred tax assets.

Although it is not reasonably possible to estimate the amount by which unrecognized tax benefits may increase or decrease within the next 12 months due to uncertainties regarding the timing of examinations and the amount of settlements that may be paid, if any, to tax authorities, the Company currently believes it is reasonably possible that only a minimal amount of gross unrecognized tax benefits will be reduced for tax positions taken in prior years within the next 12 months.

Income taxes payable of $50.8 million and $41.6 million as of March 28, 2020 and March 30, 2019, respectively, are included in "Other current liabilities" in the Consolidated Balance Sheets. Income taxes receivable of $5.4 million and $6.2 million as of March 28, 2020 and March 30, 2019, respectively, are included in “Other current assets” in the Consolidated Balance Sheets. Long-term income taxes payable of $5.6 million and $5.7 million as of March 28, 2020 and March 30, 2019, respectively, which relates to the Transitional Repatriation Tax which the Company has elected to pay over eight years, is included in "Other long-term liabilities" in the Consolidated Balance Sheets.

Qorvo files a consolidated U.S. federal income tax return, as well as separate and combined income tax returns in numerous state and international jurisdictions. Qorvo’s fiscal 2017 U.S. federal and state tax returns and subsequent tax years remain open for examination, as well as all attributes brought forward into those years. The Company is also subject to examination by various international tax authorities. The tax years subject to examination vary by jurisdiction.

Net Income (Loss) Per Share

12 Months Ended

Mar. 28, 2020

Earnings Per Share [Abstract]

NET INCOME (LOSS) PER SHARE

The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data):



	Fiscal Year
	2020		2019		2018
Numerator:
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$	334,325	$	133,125	$	(40,288	)
Denominator:
Denominator for basic net income (loss) per share — weighted average shares	117,007		124,534		126,946
Effect of dilutive securities:
Stock-based awards	2,286		2,822		—
Denominator for diluted net income (loss) per share — adjusted weighted average shares and assumed conversions	119,293		127,356		126,946
Basic net income (loss) per share	$	2.86	$	1.07	$	(0.32	)
Diluted net income (loss) per share	$	2.80	$	1.05	$	(0.32	)

In the computation of diluted net income (loss) per share for fiscal years 2020, 2019 and 2018, approximately 0.1 million shares, 0.3 million shares and 3.7 million shares, respectively, were excluded because the effect of their inclusion would have been anti-dilutive.

Stock-Based Compensation

12 Months Ended

Mar. 28, 2020

Share-based Payment Arrangement [Abstract]

STOCK-BASED COMPENSATION

Summary of Stock Plans

2003 Stock Incentive Plan - RF Micro Devices, Inc.

The 2003 Stock Incentive Plan (the "2003 Plan") was approved by the Company's stockholders on July 22, 2003, and the Company was permitted to grant stock options and other types of equity incentive awards, such as stock appreciation rights, restricted stock awards, performance shares and performance units, under the 2003 Plan. No further awards can be granted under this plan.

2006 Directors’ Stock Option Plan - RF Micro Devices, Inc.

At the Company’s 2006 annual meeting of stockholders, stockholders of the Company adopted the 2006 Directors’ Stock Option Plan, which replaced the Non-Employee Directors’ Stock Option Plan and reserved an additional 0.3 million shares of common stock for issuance to non-employee directors. Under the terms of this plan, non-employee directors were entitled to receive options to acquire shares of common stock. No further awards can be granted under this plan.

2009 and 2012 Incentive Plans - TriQuint Semiconductor, Inc.

Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2009 Incentive Plan and TriQuint, Inc. 2012 Incentive Plan (the "TriQuint Incentive Plans"), originally adopted by TriQuint. The TriQuint Incentive Plans provided for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates. The options granted thereunder were required to have an exercise price per share no less than 100% of the fair market value per share on the date of grant. The terms of each grant under the TriQuint Incentive Plans could not exceed ten years. No further awards can be granted under these plans.

2012 Stock Incentive Plan - Qorvo, Inc.

The Company currently grants stock options and restricted stock units to employees and directors under the 2012 Stock Incentive Plan (the "2012 Plan"), which was approved by the Company's stockholders on August 16, 2012, assumed by the Company in connection with the Business Combination and reapproved by the Company's

stockholders on August 8, 2017 for purposes of Section 162(m) of the Code. Under the 2012 Plan, the Company is permitted to grant stock options and other types of equity incentive awards, such as stock appreciation rights, restricted stock awards, performance shares and performance units. The maximum number of shares issuable under the 2012 Plan may not exceed the sum of (a) 4.3 million shares, plus (b) any shares of common stock (i) remaining available for issuance as of the effective date of the 2012 Plan under the Company's prior plans and (ii) subject to an award granted under a prior plan, which awards are forfeited, canceled, terminated, expire or lapse for any reason. As of March 28, 2020, 2.9 million shares were available for issuance under the 2012 Plan. The aggregate number of shares subject to performance-based restricted stock units awarded for fiscal 2020 under the 2012 Plan was 0.2 million shares.

2013 Incentive Plan - Qorvo, Inc.

Effective upon the closing of the Business Combination, the Company assumed the TriQuint, Inc. 2013 Incentive Plan (the "2013 Incentive Plan"), originally adopted by TriQuint, allowing Qorvo to issue awards under this plan. The 2013 Incentive Plan replaces the TriQuint 2012 Incentive Plan and provides for the grant of stock options, restricted stock units, stock appreciation rights and other stock or cash awards to employees, officers, directors, consultants, agents, advisors and independent contractors of TriQuint and its subsidiaries and affiliates who were such prior to the Business Combination or who become employed by the Company or its affiliates after the closing of the Business Combination. Former employees, officers and directors of RFMD are not eligible for awards under the 2013 Incentive Plan. The options granted thereunder must have an exercise price per share no less than 100% of the fair market value per share on the date of grant. The terms of each grant under the 2013 Incentive Plan may not exceed ten years. As of March 28, 2020, 1.3 million shares were available for issuance under the 2013 Incentive Plan.

2015 Inducement Stock Plan - Qorvo, Inc.

The 2015 Inducement Stock Plan (the "2015 Inducement Plan") provides for the grant of equity awards to persons as a material inducement to become employees of the Company or its affiliates. The plan provides for the grant of stock options, restricted stock units, stock appreciation rights and other stock-based awards. The maximum number of shares issuable under the 2015 Inducement Plan may not exceed the sum of (a) 0.3 million shares, plus (b) any shares of common stock (i) remaining available for issuance as of the effective date of the 2015 Inducement Stock Plan under the TriQuint 2008 Inducement Award Plan and (ii) subject to an award granted under the TriQuint 2008 Inducement Award Plan, which awards are forfeited, canceled, terminated, expire or lapse for any reason. No awards were made under the 2015 Inducement Plan in fiscal years 2020, 2019 and 2018. As of March 28, 2020, 0.3 million shares were available for issuance under the 2015 Inducement Plan.

Employee Stock Purchase Plan - Qorvo, Inc.

Effective upon closing of the Business Combination, the Company assumed the TriQuint Employee Stock Purchase Plan ("ESPP"), which is intended to qualify as an "employee stock purchase plan" under Section 423 of the Code. All regular full-time employees of the Company (including officers) and all other employees who meet the eligibility requirements of the plan may participate in the ESPP. The ESPP provides eligible employees an opportunity to acquire the Company’s common stock at 85.0% of the lower of the closing price per share of the Company’s common stock on the first or last day of each six-month purchase period. At March 28, 2020, 3.7 million shares were available for future issuance under this plan. The Company makes no cash contributions to the ESPP, but bears the expenses of its administration. The Company issued 0.5 million shares under the ESPP in fiscal years 2020, 2019 and 2018.

For fiscal years 2020, 2019 and 2018, the primary stock-based awards and their general terms and conditions are as follows:

Restricted stock units granted by the Company in fiscal years 2020, 2019 and 2018 are either service-based, performance and service-based, or based on total stockholder return. Service-based restricted stock units generally vest over a four-year period from the grant date. Performance and service-based restricted stock units are earned based on Company performance of stated metrics during the fiscal year and, if earned, generally vest one-half when earned and the balance over two years. Restricted stock units based on total stockholder return are earned based upon total stockholder return of the Company in comparison to the total stockholder return of a benchmark index and can be earned over one-, two- and three-year performance periods. Restricted stock units granted to non-employee directors generally vest over a one-year period from the grant date. In fiscal 2020, each non-employee director was eligible to receive an annual grant of restricted stock units.

The options and restricted stock units granted to certain officers of the Company generally will, in the event of the officer's termination other than for cause and subject to the officer executing certain agreements in favor of the Company, continue to vest pursuant to the same vesting schedule as if the officer had remained an employee of the Company and, as a result, these awards are expensed at grant date. In fiscal 2020, stock-based compensation of $24.1 million was recognized upon the grant of 0.3 million restricted share units to certain officers of the Company.

Stock-Based Compensation

Under ASC 718, stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award using an option pricing model for stock options (Black-Scholes) and market price for restricted stock units, and is recognized as expense over the employee's requisite service period. ASC 718 covers a wide range of stock-based compensation arrangements including stock options, restricted share plans, performance-based awards, share appreciation rights and employee stock purchase plans.

Total pre-tax stock-based compensation expense recognized in the Consolidated Statements of Operations was $76.0 million, $71.6 million and $68.2 million, for fiscal years 2020, 2019 and 2018, respectively, net of expense capitalized into inventory.

A summary of activity under the Company’s director and employee stock option plans follows:



	Shares (in thousands)	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of March 30, 2019	1,886	$	20.36
Granted	—	—
Exercised	(917)	$	22.70
Canceled	(2)	$	30.84
Forfeited	—	—
Outstanding as of March 28, 2020	967	$	18.11	2.37	$	60,529
Vested and expected to vest as of March 28, 2020	967	$	18.11	2.37	$	60,529
Options exercisable as of March 28, 2020	967	$	18.11	2.37	$	60,529

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based upon the Company’s closing stock price of $80.69 as of March 27, 2020 (the last business day prior to the fiscal year end on March 28, 2020), that would have been received by the option holders had all option holders with in-the-money options exercised their options as of that date. As of March 28, 2020, there was no remaining unearned compensation cost related to unvested option awards.

The fair value of each option award is estimated on the date of grant using a Black-Scholes option-pricing model based on the expected volatility, dividend yield, term and risk-free interest rate. There were no options granted during fiscal years 2020, 2019 and 2018.

The total intrinsic value of options exercised during fiscal years 2020, 2019 and 2018 was $65.1 million, $37.9 million and $87.8 million, respectively.

Cash received from the exercise of stock options and from participation in the employee stock purchase plan (excluding accrued unremitted employee funds) was approximately $49.5 million for fiscal 2020 and is reflected in cash flows from financing activities in the Consolidated Statements of Cash Flows. The Company settles employee stock options with newly issued shares of the Company's common stock.

ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Based upon historical pre-vesting forfeiture experience, the Company assumed an annualized forfeiture rate of 1.4% for both stock options and restricted stock units.

The following activity has occurred with respect to restricted stock unit awards:



	Shares (in thousands)	Weighted-Average Grant-Date Fair Value
Balance at March 30, 2019	1,994	$	69.03
Granted	1,146	71.88
Vested	(936)	64.89
Forfeited	(113)	69.76
Balance at March 28, 2020	2,091	$	72.59

The total intrinsic value of restricted stock units that vested during fiscal years 2020, 2019 and 2018 was $67.7 million, $77.5 million and $73.2 million, respectively, based upon the fair market value of the Company’s common stock on the vesting date.

Stockholders' Equity

12 Months Ended

Mar. 28, 2020

Equity [Abstract]

SHAREHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Stock Repurchase

On October 31, 2019, the Company announced that its Board of Directors authorized a new share repurchase program to repurchase up to $1.0 billion of the Company's outstanding common stock, which included approximately $117.0 million authorized under a prior program which was terminated concurrent with the new authorization. Under this program, share repurchases are made in accordance with applicable securities laws on the open market or in privately negotiated transactions. The extent to which the Company repurchases its shares, the number of shares and the timing of any repurchases depends on general market conditions, regulatory requirements, alternative investment opportunities and other considerations. The program does not require the Company to repurchase a minimum number of shares, does not have a fixed term, and may be modified, suspended or terminated at any time without prior notice.

The Company repurchased 6.4 million shares, 9.1 million shares and 2.9 million shares of its common stock during fiscal years 2020, 2019 and 2018, respectively, at an aggregate cost of $515.1 million, $638.1 million and $219.9 million, respectively, in accordance with the current and prior share repurchase programs. As of March 28, 2020, $765.9 million remains available for future repurchases under the Company's current share repurchase program.

Common Stock Reserved For Future Issuance

At March 28, 2020, the Company had reserved a total of approximately 11.2 million of its authorized 405.0 million shares of common stock for future issuance as follows (in thousands):



Outstanding stock options under formal directors’ and employees’ stock option plans	967
Possible future issuance under Company stock incentive plans	4,515
Employee stock purchase plan	3,673
Restricted stock-based units outstanding	2,091
Total shares reserved	11,246

Operating Segment and Geographical Information

12 Months Ended

Mar. 28, 2020

Segment Reporting [Abstract]

OPERATING SEGMENT AND GEOGRAPHIC INFORMATION

The Company's operating and reportable segments as of March 28, 2020 are MP and IDP based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), and these segments are managed separately based on the end markets and applications they support. The CODM allocates resources and assesses the performance of each operating segment primarily based on non-GAAP operating income.

MP is a global supplier of cellular, UWB and Wi-Fi solutions for a variety of high-volume markets, including smartphones, wearables, laptops, tablets and IoT applications.

IDP is a global supplier of RF, system-on-a-chip and power management solutions for wireless infrastructure, defense, smart home, automotive and other IoT applications.

The "All other" category includes operating expenses such as stock-based compensation, amortization of intangible assets, acquisition and integration related costs, restructuring related charges, start-up costs, asset impairment and accelerated depreciation, (loss) gain on assets, and other miscellaneous corporate overhead expenses that the Company does not allocate to its reportable segments because these expenses are not included in the segment operating performance measures evaluated by the Company’s CODM. The CODM does not evaluate operating segments using discrete asset information. The Company’s operating segments do not record intercompany revenue. The Company does not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Except as discussed above regarding the "All other" category, the Company’s accounting policies for segment reporting are the same as for the Company as a whole.

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):



	Fiscal Year
	2020			2019			2018
Revenue:
MP	$	2,397,740		$	2,197,660		$	2,181,161
IDP	841,401			892,665			788,495
All other (1)	—			—			3,880
Total revenue	$	3,239,141		$	3,090,325		$	2,973,536
Operating income (loss):
MP	$	715,514		$	558,990		$	549,574
IDP	145,295			267,304			235,719
All other	(437,593		)	(609,828		)	(715,011		)
Operating income	$	423,216		$	216,466		$	70,282
Interest expense	$	(60,392	)	$	(43,963	)	$	(59,548	)
Interest income	12,066			10,971			7,017
Other income (expense)	20,199			(91,682		)	(606		)
Income before income taxes	$	395,089		$	91,792		$	17,145

(1) "All other" revenue relates to royalty income that was not allocated to MP or IDP for fiscal 2018. As a result of the adoption of ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)," income related to a right-to-use license of intellectual property was recognized at a point-in-time and, therefore, was included as a transition adjustment impacting retained earnings.



	Fiscal Year
	2020			2019			2018
Reconciliation of "All other" category:
Stock-based compensation expense	$	(75,978	)	$	(71,580	)	$	(68,158	)
Amortization of intangible assets	(246,563		)	(453,515		)	(539,362		)
Acquisition and integration related costs	(61,891		)	(8,522		)	(10,561		)
Restructuring related charges	(21,808		)	(13,467		)	(21,406		)
Start-up costs	(712		)	(18,035		)	(24,271		)
Asset impairment and accelerated depreciation	(27,118		)	(37,246		)	(38,000		)
Other (including (loss) gain on assets and other miscellaneous corporate overhead)	(3,523		)	(7,463		)	(13,253		)
Loss from operations for "All other"	$	(437,593	)	$	(609,828	)	$	(715,011	)

The consolidated financial statements include revenue to customers by geographic region that are summarized as follows (in thousands):



	Fiscal Year
	2020		2019		2018
Revenue:
United States	$	1,468,358	$	1,379,528	$	1,463,594
China	1,106,679		1,094,061		890,969
Other Asia	340,400		271,797		327,158
Taiwan	169,337		188,745		161,479
Europe	154,367		156,194		130,336
Total Revenue	$	3,239,141	$	3,090,325	$	2,973,536

During the first quarter of fiscal 2020, the Company changed its presentation of net revenue based on the "sold to" address of the customer to the above presentation of net revenue based on the location of the customers' headquarters. The information above for fiscal years 2019 and 2018 has been reclassified to reflect this change. The Company believes that the disaggregation of revenue based on the location of the customers' headquarters is more representative of how its revenue and cash flows are impacted by geographically-sensitive changes in economic factors.

The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands):



	March 28, 2020		March 30, 2019
Long-lived tangible assets:
United States	$	1,042,587	$	1,106,705
China	166,524		216,342
Other countries	50,092		43,466

Quarterly Financial Summary (Unaudited)

12 Months Ended

Mar. 28, 2020

Quarterly Financial Information Disclosure [Abstract]

QUARTERLY FINANCIAL SUMMARY (UNAUDITED)

QUARTERLY FINANCIAL SUMMARY (UNAUDITED):



	Fiscal 2020 Quarter
(in thousands, except per share data)	First				Second			Third			Fourth
Revenue	$	775,598			$	806,698		$	869,073		$	787,772
Gross profit	294,289				323,582			368,111			335,781
Net income	39,541			^(1),(2),(3)	83,038		^(1),(3)	161,356		^{(1),(2),(3),(4)}	50,390		^{(1),(2),(3),(5)}
Net income per share:
Basic	$	0.33			$	0.71		$	1.39		$	0.44
Diluted	$	0.33			$	0.70		$	1.36		$	0.43

	Fiscal 2019 Quarter
(in thousands, except per share data)	First				Second			Third			Fourth
Revenue	$	692,670			$	884,443		$	832,330		$	680,882
Gross profit	236,733				353,514			338,363		⁽¹⁾	266,573		⁽¹⁾
Net (loss) income	(29,993		)	^{(1),(2),(6),(7)}	32,084		^(1),(2),(6)	69,517		^(1),(2),(6)	61,517		^(1),(6),(8)
Net (loss) income per share:
Basic	$	(0.24	)		$	0.26		$	0.56		$	0.51
Diluted	$	(0.24	)		$	0.25		$	0.55		$	0.50

1 The Company recorded restructuring related charges, including accelerated depreciation on certain property and equipment, of $24.0 million, $9.5 million, $10.3 million and $4.1 million in the first, second, third and fourth quarters of fiscal 2020, respectively. The Company recorded restructuring related charges, including accelerated depreciation and impairment charges on certain property and equipment, of $2.8 million, $0.5 million, $19.5 million and $27.9 million in the first, second, third and fourth quarters of fiscal 2019, respectively (Note 12).

2 The Company recorded start-up expenses of $0.1 million, $0.4 million and $0.2 million in the first, third and fourth quarters of fiscal 2020, respectively. The Company recorded start-up expenses of $5.3 million, $5.9 million and $6.8 million in the first, second and third quarters of fiscal 2019, respectively.

3 The Company recorded acquisition and integration related expenses of $23.1 million, $7.6 million, $7.2 million and $24.0 million in the first, second, third and fourth quarters of fiscal 2020, respectively, primarily associated with the acquisitions of Active-Semi, Cavendish, Custom MMIC and Decawave (Note 5).

4 The Company recorded a gain of $43.0 million in the third quarter of fiscal 2020 related to the remeasurement of its previously held equity interest in Cavendish in connection with the purchase of the remaining issued and outstanding capital of the entity (Note 5).

5 The Company recorded an impairment of $18.3 million in the fourth quarter of fiscal 2020 on an equity investment without a readily determinable fair value (Note 7).

6 The Company recorded losses on debt extinguishment of $33.4 million, $48.8 million, $1.8 million and $6.2 million in the first, second, third and fourth quarters of fiscal 2019, respectively.

7 Income tax benefit of $32.1 million for the first quarter of fiscal 2019 relates primarily to a discrete provisional benefit for adjustments to a third quarter fiscal 2018 provisional estimate of the impact of the Tax Act (Note 13).

8 Income tax benefit of $11.3 million for the fourth quarter of fiscal 2019 relates primarily to a discrete benefit for the recognition of a previously unrecognized tax benefit as a result of legislative guidance issued during the year (Note 13).

The Company uses a 52- or 53-week fiscal year ending on the Saturday closest to March 31 of each year. The first fiscal quarter of each year ends on the Saturday closest to June 30, the second fiscal quarter of each year ends on the Saturday closest to September 30 and the third fiscal quarter of each year ends on the Saturday closest to December 31. Each quarter of fiscal 2020 and fiscal 2019 contained a comparable number of weeks (13 weeks).

The Company and Its Significant Accounting Policies (Policies)

12 Months Ended

Mar. 28, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Principles of Consolidation and Basis of Presentation

Accounting Periods

Use of Estimates

Cash and Cash Equivalents

Cash and cash equivalents consist of demand deposit accounts, money market funds, and other temporary, highly-liquid investments with original maturities of three months or less when purchased.

Investments

current investments. Available-for-sale debt securities with an original maturity date exceeding one year are classified as long-term.

Fair Value Measurement


•	Level 1 - includes instruments for which inputs are quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.


•	Level 2 - includes instruments for which the inputs are other than quoted prices that are observable for the asset or liability, either directly or indirectly, and fair value can be determined through the use of models or other valuation methodologies that do not require significant judgment since the inputs are corroborated by readily observable data.


•	Level 3 - includes instruments for which the valuations are based on inputs that are unobservable and significant to the overall fair value measurement. These inputs are supported by little or no market activity and reflect the use of significant management judgment.

Inventories

Product Warranty

Property and Equipment

Lessee, Leases [Policy Text Block]

Leases

Business Combinations Policy [Policy Text Block]

Business Acquisitions

Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]

Goodwill

Goodwill is allocated to the reporting units that are expected to benefit from the synergies of the business combinations generating the underlying goodwill.

Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]

Identified Intangible Assets

Accrued Liabilities

Revenue Recognition

Research and Development

The Company charges all R&D costs to expense as incurred.

Income Taxes

Stock-Based Compensation

Foreign Currency Translation

Recent Accounting Pronouncements

Accounting Pronouncements Not Yet Effective

Accounting Pronouncements Recently Adopted

Goodwill and Intangible Assets Policies (Policies)	12 Months Ended
Goodwill and Intangible Assets Policies (Policies)	Mar. 28, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill The Company performs an annual impairment assessment of goodwill at the reporting unit level on the first day of the fourth quarter in each fiscal year, or more frequently if indicators of potential impairment exist. Reporting units, as defined by Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 350, "Intangibles - Goodwill and Other," may be operating segments as a whole or an operation one level below an operating segment, referred to as a component. The Company has determined that its reporting units are its two operating and reportable segments, Mobile Products ("MP") and Infrastructure and Defense Products ("IDP"). In accordance with ASC 350, the Company may assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value, including goodwill. In performing a qualitative assessment, the Company considers (i) its overall historical and projected future operating results, (ii) if there was a significant decline in the Company’s stock price for a sustained period, (iii) if there was a significant change in the Company’s market capitalization relative to its net book value, and (iv) if there was a prolonged or more significant slowdown in the worldwide economy of the semiconductor industry, as well as other relevant events and factors affecting the reporting unit. If the Company assesses these qualitative factors and concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, or if the Company decides not to perform a qualitative assessment, then a quantitative impairment test is performed. In fiscal years 2019 and 2018, the Company completed qualitative assessments and concluded that based on the relevant facts and circumstances, it was more likely than not that each reporting unit’s fair value exceeded its related carrying value and no further impairment testing was required. In fiscal 2020, the Company performed a quantitative impairment test. The Company’s quantitative impairment test considered both the income approach and the market approach to estimate each reporting unit’s fair value. Under the income approach, the fair value of each reporting unit is based on the present value of estimated future cash flows. Cash flow projections are based on the Company's estimates of revenue growth rates and operating margins, taking into consideration industry and market conditions. The discount rate used to determine the present value of future cash flows is based on the weighted-average cost of capital adjusted for the relevant risk associated with business-specific characteristics and the uncertainty related to the business's ability to execute on the projected cash flows. The market approach estimates fair value based on market multiples of revenue and earnings derived from comparable publicly traded companies with similar operating and investment characteristics. The resulting fair value, based on the income and market approaches, is then compared to the carrying value to determine if impairment is necessary. As a result of the quantitative analysis performed in fiscal 2020, it was determined that the fair value of each of the Company’s reporting units substantially exceeded their carrying values. As the assumptions used in the income approach and market approach can have a material impact on the fair value determinations, the Company performed a sensitivity analysis of key assumptions used in the assessment and determined that a one percentage point increase in the discount rate along with a one percentage point decrease in the long-term growth rate would not result in an impairment of goodwill for either reporting unit and their fair values substantially exceeded their carrying values. Goodwill is allocated to the reporting units that are expected to benefit from the synergies of the business combinations generating the underlying goodwill.

Operating Segment and Geographic Information Policies (Policies)	12 Months Ended
	Mar. 28, 2020
Segment Reporting [Abstract]
Segment Reporting, Policy [Policy Text Block]	The Company's operating and reportable segments as of March 28, 2020 are MP and IDP based on the organizational structure and information reviewed by the Company's Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), and these segments are managed separately based on the end markets and applications they support. The CODM allocates resources and assesses the performance of each operating segment primarily based on non-GAAP operating income.

Concentrations of Credit Risk (Tables)

12 Months Ended

Mar. 28, 2020

Risks and Uncertainties [Abstract]

Revenue from significant customers

Revenue from significant customers, those representing 10% or more of revenue for the respective periods, are summarized as follows:



	Fiscal Year
	2020	2019	2018
Apple Inc. ("Apple") (1)	33%	32%	36%
Huawei Technologies Co., Ltd. and affiliates ("Huawei")	10%	15%	8%

(1) The Company provided its products to Apple through sales to multiple contract manufacturers.

Inventories (Tables)

12 Months Ended

Mar. 28, 2020

Inventory Disclosure [Abstract]

Components of inventories

The components of inventories, net of reserves, are as follows (in thousands):



	March 28, 2020		March 30, 2019
Raw materials	$	112,671	$	118,608
Work in process	291,028		272,469
Finished goods	113,499		120,716
Total inventories	$	517,198	$	511,793

Property and Equipment (Tables)

12 Months Ended

Mar. 28, 2020

Property, Plant and Equipment [Abstract]

Property, Plant and Equipment [Table Text Block]

The components of property and equipment are as follows (in thousands):



	March 28, 2020			March 30, 2019
Land	$	25,842		$	25,996
Building and leasehold improvements	404,075			416,209
Machinery and equipment	2,145,511			2,025,110
	2,575,428			2,467,315
Less accumulated depreciation	(1,415,397		)	(1,218,507		)
	1,160,031			1,248,808
Construction in progress	99,172			117,705
Total property and equipment, net	$	1,259,203		$	1,366,513

Business Acquisitions Business Acquisitions (Tables)

12 Months Ended

Feb. 21, 2020

Feb. 06, 2020

Oct. 04, 2019

May 06, 2019

Mar. 28, 2020

Business Acquisitions [Abstract]

Business Combination, Fair Value of Consideration [Table Text Block]

The purchase price was calculated as follows (in thousands):



Cash consideration paid to Cavendish	$	198,385
Fair value of equity interest previously held by the Company	102,383
Total purchase price	$	300,768

Custom MMIC Purchase Price Allocation [Table Text Block]

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):



Net tangible assets (1)	$	4,988
Intangible assets	31,100
Goodwill	55,654
	$	91,742

(1) Includes cash acquired of $2.3 million.

Active-Semi Purchase Price Allocation [Table Text Block]

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):



Net tangible assets (1)	$	22,876
Intangible assets	158,400
Goodwill	130,802
Deferred tax liability, net	(4,184		)
	$	307,894

(1) Includes cash acquired of $10.0 million.

Cavendish Purchase Price Allocation [Table Text Block]

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):



Net tangible assets (1)	$	97
Intangible assets	206,350
Goodwill	100,845
Deferred tax liability, net	(6,524		)
	$	300,768

(1) Includes cash acquired of $1.8 million.

Decawave Purchase Price Allocation [Table Text Block]

The purchase price was allocated based on the estimated fair values of the assets acquired and liabilities assumed as follows (in thousands):



Net tangible assets (1)	$	304
Intangible assets	246,060
Goodwill	149,703
Deferred tax liability, net	(21,327		)
	$	374,740

(1) Includes cash acquired of $5.0 million.

Goodwill and Intangible Assets (Tables)

12 Months Ended

Mar. 28, 2020

Indefinite-lived Intangible Assets [Line Items]

Schedule of Goodwill [Table Text Block]

The changes in the carrying amount of goodwill for fiscal 2020 are as follows (in thousands):



	Mobile Products		Infrastructure and Defense Products		Total
Balance as of March 30, 2019 (1)	$	1,751,503	$	422,386	$	2,173,889
Active-Semi acquisition	—		130,802		130,802
Cavendish acquisition	100,845		—		100,845
Custom MMIC acquisition	—		55,654		55,654
Decawave acquisition	149,703		—		149,703
Effect of changes in foreign currency exchange rates (2)	3,381		—		3,381
Balance as of March 28, 2020 (1)	$	2,005,432	$	608,842	$	2,614,274

(1) The Company’s goodwill balance is presented net of accumulated impairment losses and write-offs of $621.6 million.

(2) Represents the impact of foreign currency translation when goodwill is recorded in foreign entities whose functional currency is also their local currency.

Schedule of Finite-Lived and Indefinite-Lived Intangible Assets [Table Text Block]

The following summarizes information regarding the gross carrying amounts and accumulated amortization of intangible assets (in thousands):



	March 28, 2020				March 30, 2019
	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Developed technology	$	1,325,472	$	652,400	$	1,246,335	$	960,793
Customer relationships	463,772		346,799		1,272,725		1,161,735
Technology licenses	3,271		2,327		14,704		13,026
Backlog	1,600		267		—		—
Trade names	1,200		283		29,391		29,391
Non-compete agreement	—		—		1,026		1,026
IPRD	9,600		N/A		10,000		N/A
Effect of changes in foreign currency exchange rates (1)	6,064		11		—		—
Total	$	1,810,979	$	1,002,087	$	2,574,181	$	2,165,971

(1) Represents the impact of foreign currency translation when intangibles are recorded in foreign entities whose functional currency is also their local currency.

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

The following table provides the Company's estimated amortization expense for intangible assets based on current amortization periods for the periods indicated (in thousands):



Fiscal Year	Estimated Amortization Expense
2021	$	248,000
2022	119,000
2023	103,000
2024	90,000
2025	76,000

Investments and Fair Value Measurements (Tables)

12 Months Ended

Mar. 28, 2020

Schedule of available-for-sale debt securities

Fair value of the financial assets measured at fair value on a recurring basis

The fair value of the financial assets and liabilities measured on a recurring basis was determined using the following levels of inputs as of March 28, 2020 and March 30, 2019 (in thousands):



				Total		Quoted Prices In Active Markets For Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
March 28, 2020
	Assets
		Marketable equity securities		$	459	$	459	$	—	$	—
		Invested funds in deferred compensation plan (1)		19,398		19,398		—		—
			Total assets measured at fair value	$	19,857	$	19,857	$	—	$	—
	Liabilities
		Deferred compensation plan obligation (1)		$	19,398	$	19,398	$	—	$	—
		Contingent earn-out liability (2)		5,700		—		—		5,700
			Total liabilities measured at fair value	$	25,098	$	19,398	$	—	$	5,700

March 30, 2019
	Assets
		Money market funds		$	13	$	13	$	—	$	—
		Marketable equity securities		901		901		—		—
		Auction rate securities (3)		1,950		—		1,950		—
		Invested funds in deferred compensation plan (1)		18,737		18,737		—		—
			Total assets measured at fair value	$	21,601	$	19,651	$	1,950	$	—
	Liabilities
		Deferred compensation plan obligation (1)		$	18,737	$	18,737	$	—	$	—
			Total liabilities measured at fair value	$	18,737	$	18,737	$	—	$	—

Leases (Tables)

12 Months Ended

Mar. 28, 2020

Leases [Abstract]

Schedule of Future Minimum Lease Payments for Capital Leases and Operating Leases [Table Text Block]



2020	$	22,207
2021	13,382
2022	10,331
2023	8,224
2024	7,139
Thereafter	31,598
Total minimum payments	$	92,881

Schedule of supplemental balance sheet information related to operating leases [Table Text Block]

Operating leases as of March 28, 2020 are classified as follows (in thousands):



Other non-current assets	$	65,107

Other current liabilities	$	15,917
Other long-term liabilities	$	58,077

Schedule of lease costs, weighted-average remaining lease term and discount rate, and supplemental cash/non-cash information related to operating leases [Table Text Block]

Details of operating leases for fiscal 2020 are as follows (in thousands):



Operating lease expense	$	15,184
Short-term lease expense	$	6,878
Variable lease expense	$	3,098

Cash paid for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$	16,504

Operating lease assets obtained in exchange for new lease liabilities	$	13,201

Weighted-average remaining lease term (years)	7.8
Weighted-average discount rate	4.06		%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

The aggregate future lease payments for operating leases as of March 28, 2020 are as follows (in thousands):



2021	$	21,586
2022	14,201
2023	9,690
2024	7,449
2025	6,006
Thereafter	27,194
Total lease payments	86,126
Less imputed interest	(12,132		)
Present value of lease liabilities	$	73,994

Debt (Tables)

12 Months Ended

Mar. 28, 2020

Debt Disclosure [Abstract]

Schedule of Maturities of Long-term Debt [Table Text Block]

The annual maturities of the Term Loan as of March 28, 2020 are as follows (in thousands):



Fiscal Year	Maturities
2021	$	6,250
2022	5,000
2023	88,750
	$	100,000

Schedule of Long-term Debt Instruments [Table Text Block]

Debt as of March 28, 2020 and March 30, 2019 is as follows (in thousands):



	March 28, 2020			March 30, 2019
Term loan	$	100,000		$	—
7.00% senior notes due 2025	23,404			23,404
5.50% senior notes due 2026	900,000			900,000
4.375% senior notes due 2029	550,000			—
Finance leases	2,252			1,745
Less unamortized premium and issuance costs, net	(1,532		)	(4,134		)
Less current portion of long-term debt	(6,893		)	(80		)
Total long-term debt	$	1,567,231		$	920,935

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Restructuring Tables (Tables)

12 Months Ended

Mar. 28, 2020

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs [Table Text Block]

The following table summarizes the restructuring charges primarily resulting from these restructuring events (in thousands):



	Fiscal 2020
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	6,289	$	6,289
Contract termination and other associated costs	8,365		7,154		15,519
Accelerated depreciation	26,061		—		26,061
Total	$	34,426	$	13,443	$	47,869

	Fiscal 2019
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	12,826	$	12,826
Contract termination and other associated costs	—		641		641
Asset impairment and accelerated depreciation	21,346		15,901		37,247
Total	$	21,346	$	29,368	$	50,714

	Fiscal 2018
	Cost of Goods Sold		Other Operating Expense		Total
One-time employee termination benefits	$	—	$	19,232	$	19,232
Contract termination and other associated costs	—		2,174		2,174
Asset impairment	—		46,315		46,315
Total	$	—	$	67,721	$	67,721

The following table summarizes the activity related to the Company's restructuring liabilities for fiscal years 2019 and 2020 (in thousands):



	One-Time Employee Termination Benefits			Asset Impairment and Accelerated Depreciation			Contract Termination and Other Associated Costs			Total
Accrued restructuring balance as of March 31, 2018	$	6,130		$	—		$	2,557		$	8,687
Costs incurred and charged to expense	12,826			37,247			641			50,714
Cash payments	(11,968		)	—			(1,572		)	(13,540		)
Non-cash activity	—			(37,247		)	—			(37,247		)
Accrued restructuring balance as of March 30, 2019	$	6,988		$	—		$	1,626		$	8,614
Costs incurred and charged to expense	6,289			26,061			15,519			47,869
Transfer to right-of-use asset	—			—			(1,248		)	(1,248		)
Cash payments	(11,549		)	—			(7,262		)	(18,811		)
Non-cash activity	—			(26,061		)	(8,365		)	(34,426		)
Accrued restructuring balance as of March 28, 2020	$	1,728		$	—		$	270		$	1,998

Income Taxes (Tables)

12 Months Ended

Mar. 28, 2020

Income Tax Disclosure [Abstract]

Income before income taxes

Income (loss) before income taxes consists of the following components (in thousands):



	Fiscal Year
	2020			2019			2018
United States	$	(226,005	)	$	(297,975	)	$	(151,083	)
Foreign	621,094			389,767			168,228
Total	$	395,089		$	91,792		$	17,145

Components of the income tax (provision) benefit

The components of the income tax provision are as follows (in thousands):



	Fiscal Year
	2020			2019			2018
Current (expense) benefit:
Federal	$	(6,705	)	$	17,222		$	(28,168	)
State	(93		)	209			(229		)
Foreign	(65,065		)	(46,267		)	(61,284		)
	(71,863		)	(28,836		)	(89,681		)
Deferred benefit (expense):
Federal	$	7,826		$	55,833		$	11,817
State	4,603			946			253
Foreign	(1,330		)	13,390			20,178
	11,099			70,169			32,248
Total	$	(60,764	)	$	41,333		$	(57,433	)

Reconciliation of the (provision for) or benefit from income taxes to income tax(expense) or benefit computed by applying the statutory federal income tax rate to pre-tax income.



	Fiscal Year
	2020					2019					2018
	Amount			Percentage		Amount			Percentage		Amount			Percentage
Income tax expense at statutory federal rate	$	(82,969	)	21.0	%	$	(19,276	)	21.0	%	$	(5,407	)	31.5	%
(Increase) decrease resulting from:
State benefit, net of federal expense	2,605			(0.7	)	710			(0.8	)	474			(2.8	)
Tax credits	64,017			(16.2	)	69,856			(76.1	)	38,054			(221.9	)
Effect of changes in income tax rate applied to net deferred tax assets	(2,269		)	0.6		12,972			(14.1	)	39,168			(228.4	)
Foreign tax rate difference	75,247			(19.0	)	41,672			(45.4	)	21,829			(127.3	)
Foreign permanent differences and related items	(5,446		)	1.4		6,825			(7.4	)	(2,598		)	15.2
Change in valuation allowance	6,438			(1.6	)	2,353			(2.6	)	(1,632		)	9.5
Expiration of state attributes	(5,165		)	1.3		—			—		—			—
Stock-based compensation	(1,707		)	0.4		(7,694		)	8.4		9,924			(57.9	)
Tax reserve adjustments	(13,973		)	3.5		5,213			(5.7	)	(29,188		)	170.2
U.S. tax on foreign earnings, including GILTI	(81,916		)	20.8		(76,215		)	83.0		(5,098		)	29.7
U.S. Transitional Repatriation Tax	—			—		1,897			(2.1	)	(116,419		)	679.0
Intra-entity transfer	—			—		3,935			(4.3	)	(6,873		)	40.1
Permanent reinvestment assertion	(6,814		)	1.7		—			—		—			—
Acquisition related adjustments	(7,257		)	1.8		—			—		—			—
Other income tax (expense) benefit	(1,555		)	0.4		(915		)	1.1		333			(1.9	)
	$	(60,764	)	15.4	%	$	41,333		(45.0	)%	$	(57,433	)	335.0	%

Significant components of net deferred income taxes

Significant components of the Company’s net deferred income taxes are as follows (in thousands):



	March 28, 2020			March 30, 2019
Deferred income tax assets:
Inventory reserve	$	10,114		$	8,588
Equity compensation	18,817			27,380
Net operating loss carry-forwards	71,928			13,744
Research and other credits	106,958			95,640
Employee benefits	12,606			13,070
Lease liabilities	16,456			—
Other deferred assets	3,559			19,457
Total deferred income tax assets	240,438			177,879
Valuation allowance	(35,280		)	(40,433		)
Total deferred income tax assets, net of valuation allowance	$	205,158		$	137,446

Deferred income tax liabilities:
Amortization and purchase accounting basis difference	$	(107,517	)	$	(45,665	)
Accumulated depreciation/basis difference	(59,356		)	(62,097		)
Accrued tax on unremitted foreign earnings	(15,521		)	—
Right-of-use assets	(14,400		)	—
Other deferred liabilities	(1,955		)	—
Total deferred income tax liabilities	(198,749		)	(107,762		)
Net deferred income tax asset	$	6,409		$	29,684

Amounts included in the Consolidated Balance Sheets:
Other non-current assets	$	45,754		$	30,017
Other long-term liabilities	(39,345		)	(333		)
Net deferred income tax asset	$	6,409		$	29,684

Reconciliation of gross unrecognized tax benefits

A reconciliation of fiscal 2018 through fiscal 2020 beginning and ending amount of gross unrecognized tax benefits is as follows (in thousands):



	Fiscal Year
	2020			2019			2018
Beginning balance	$	103,178		$	122,823		$	90,615
Additions based on positions related to current year	10,357			7,193			26,431
Additions for tax positions in prior years	6,484			8,369			5,844
Reductions for tax positions in prior years	(69		)	(24,932		)	(67		)
Expiration of statute of limitations	(728		)	(6,972		)	—
Settlements	—			(3,303		)	—
Ending balance	$	119,222		$	103,178		$	122,823

Net Income (Loss) Per Share (Tables)

12 Months Ended

Mar. 28, 2020

Earnings Per Share [Abstract]

Reconciliation of the numerators and denominators in the computation of basic and diluted net income (loss) per share

The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data):



	Fiscal Year
	2020		2019		2018
Numerator:
Numerator for basic and diluted net income (loss) per share — net income (loss) available to common stockholders	$	334,325	$	133,125	$	(40,288	)
Denominator:
Denominator for basic net income (loss) per share — weighted average shares	117,007		124,534		126,946
Effect of dilutive securities:
Stock-based awards	2,286		2,822		—
Denominator for diluted net income (loss) per share — adjusted weighted average shares and assumed conversions	119,293		127,356		126,946
Basic net income (loss) per share	$	2.86	$	1.07	$	(0.32	)
Diluted net income (loss) per share	$	2.80	$	1.05	$	(0.32	)

Stock-Based Compensation (Tables)

12 Months Ended

Mar. 28, 2020

Share-based Payment Arrangement [Abstract]

Summary of activity of the Company's director and employee stock option plans

A summary of activity under the Company’s director and employee stock option plans follows:



	Shares (in thousands)	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in thousands)
Outstanding as of March 30, 2019	1,886	$	20.36
Granted	—	—
Exercised	(917)	$	22.70
Canceled	(2)	$	30.84
Forfeited	—	—
Outstanding as of March 28, 2020	967	$	18.11	2.37	$	60,529
Vested and expected to vest as of March 28, 2020	967	$	18.11	2.37	$	60,529
Options exercisable as of March 28, 2020	967	$	18.11	2.37	$	60,529

Restricted share plans

The following activity has occurred with respect to restricted stock unit awards:



	Shares (in thousands)	Weighted-Average Grant-Date Fair Value
Balance at March 30, 2019	1,994	$	69.03
Granted	1,146	71.88
Vested	(936)	64.89
Forfeited	(113)	69.76
Balance at March 28, 2020	2,091	$	72.59

Stockholders' Equity (Tables)

12 Months Ended

Mar. 28, 2020

Equity [Abstract]

Common stock reserved for future issuance

At March 28, 2020, the Company had reserved a total of approximately 11.2 million of its authorized 405.0 million shares of common stock for future issuance as follows (in thousands):



Outstanding stock options under formal directors’ and employees’ stock option plans	967
Possible future issuance under Company stock incentive plans	4,515
Employee stock purchase plan	3,673
Restricted stock-based units outstanding	2,091
Total shares reserved	11,246

Operating Segment and Geographical Information (Tables)

12 Months Ended

Mar. 28, 2020

Segment Reporting [Abstract]

Summary of details of reportable segments

The following tables present details of the Company’s operating and reportable segments and a reconciliation of the "All other" category (in thousands):



	Fiscal Year
	2020			2019			2018
Revenue:
MP	$	2,397,740		$	2,197,660		$	2,181,161
IDP	841,401			892,665			788,495
All other (1)	—			—			3,880
Total revenue	$	3,239,141		$	3,090,325		$	2,973,536
Operating income (loss):
MP	$	715,514		$	558,990		$	549,574
IDP	145,295			267,304			235,719
All other	(437,593		)	(609,828		)	(715,011		)
Operating income	$	423,216		$	216,466		$	70,282
Interest expense	$	(60,392	)	$	(43,963	)	$	(59,548	)
Interest income	12,066			10,971			7,017
Other income (expense)	20,199			(91,682		)	(606		)
Income before income taxes	$	395,089		$	91,792		$	17,145

Summary of reconciliation of All other category



	Fiscal Year
	2020			2019			2018
Reconciliation of "All other" category:
Stock-based compensation expense	$	(75,978	)	$	(71,580	)	$	(68,158	)
Amortization of intangible assets	(246,563		)	(453,515		)	(539,362		)
Acquisition and integration related costs	(61,891		)	(8,522		)	(10,561		)
Restructuring related charges	(21,808		)	(13,467		)	(21,406		)
Start-up costs	(712		)	(18,035		)	(24,271		)
Asset impairment and accelerated depreciation	(27,118		)	(37,246		)	(38,000		)
Other (including (loss) gain on assets and other miscellaneous corporate overhead)	(3,523		)	(7,463		)	(13,253		)
Loss from operations for "All other"	$	(437,593	)	$	(609,828	)	$	(715,011	)

Sales to customers by geographic region

The consolidated financial statements include revenue to customers by geographic region that are summarized as follows (in thousands):



	Fiscal Year
	2020		2019		2018
Revenue:
United States	$	1,468,358	$	1,379,528	$	1,463,594
China	1,106,679		1,094,061		890,969
Other Asia	340,400		271,797		327,158
Taiwan	169,337		188,745		161,479
Europe	154,367		156,194		130,336
Total Revenue	$	3,239,141	$	3,090,325	$	2,973,536

Long-lived assets by geographic region

The consolidated financial statements include the following long-lived tangible asset amounts related to operations of the Company by geographic region (in thousands):



	March 28, 2020		March 30, 2019
Long-lived tangible assets:
United States	$	1,042,587	$	1,106,705
China	166,524		216,342
Other countries	50,092		43,466

Quarterly Financial Summary (Unaudited) (Tables)

12 Months Ended

Mar. 28, 2020

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Summary (Unaudited)

QUARTERLY FINANCIAL SUMMARY (UNAUDITED):



	Fiscal 2020 Quarter
(in thousands, except per share data)	First				Second			Third			Fourth
Revenue	$	775,598			$	806,698		$	869,073		$	787,772
Gross profit	294,289				323,582			368,111			335,781
Net income	39,541			^(1),(2),(3)	83,038		^(1),(3)	161,356		^{(1),(2),(3),(4)}	50,390		^{(1),(2),(3),(5)}
Net income per share:
Basic	$	0.33			$	0.71		$	1.39		$	0.44
Diluted	$	0.33			$	0.70		$	1.36		$	0.43

	Fiscal 2019 Quarter
(in thousands, except per share data)	First				Second			Third			Fourth
Revenue	$	692,670			$	884,443		$	832,330		$	680,882
Gross profit	236,733				353,514			338,363		⁽¹⁾	266,573		⁽¹⁾
Net (loss) income	(29,993		)	^{(1),(2),(6),(7)}	32,084		^(1),(2),(6)	69,517		^(1),(2),(6)	61,517		^(1),(6),(8)
Net (loss) income per share:
Basic	$	(0.24	)		$	0.26		$	0.56		$	0.51
Diluted	$	(0.24	)		$	0.25		$	0.55		$	0.50

5 The Company recorded an impairment of $18.3 million in the fourth quarter of fiscal 2020 on an equity investment without a readily determinable fair value (Note 7).

6 The Company recorded losses on debt extinguishment of $33.4 million, $48.8 million, $1.8 million and $6.2 million in the first, second, third and fourth quarters of fiscal 2019, respectively.

The Company and Its Significant Accounting Policies (Details) - USD ($)	3 Months Ended	12 Months Ended
	Jun. 29, 2019	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
The Company and Its Significant Accounting Policies [Line Items]
Goodwill, Impairment Loss		$ 0	$ 0	$ 0
Revenue for product and services over time as a percent of total revenue		2.00%
Revenue, Remaining Performance Obligation, Amount		$ 37,800,000
Accrued compensation and benefits		126,100,000	93,200,000
Interest Payable		$ 22,800,000	$ 11,200,000
Rebates As Percentage Of Sales [Less Than]		5.00%
Minimum
The Company and Its Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life		1 year
Maximum
The Company and Its Significant Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life		39 years
Restricted Stock
The Company and Its Significant Accounting Policies [Line Items]
Total remaining unearned compensation cost related to nonvested restricted stock units and options		$ 87,400,000
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units and options		1 year 3 months 18 days
Accounting Standards Update 2016-02 [Member] \| Right-of-Use Asset [Member]
The Company and Its Significant Accounting Policies [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 70,700,000
Accounting Standards Update 2016-02 [Member] \| Lease Liability [Member]
The Company and Its Significant Accounting Policies [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	75,000,000.0
Accounting Standards Update 2016-02 [Member] \| Retained Earnings
The Company and Its Significant Accounting Policies [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 100,000

Concentrations of Credit Risk (Details) - Sales Revenue, Net - Customer Concentration Risk	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Apple
Revenue from significant customers
Percentage	33.00%	32.00%	36.00%
Huawei
Revenue from significant customers
Percentage	10.00%	15.00%	8.00%

Concentrations of Credit Risk (Details Textual)	12 Months Ended
Concentrations of Credit Risk (Details Textual)	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Accounts Receivable \| Credit Concentration Risk
Concentrations of Credit Risk (Textual)
Percentage	35.00%	49.00%	26.00%

Inventories (Details) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019
Components of inventories
Raw materials	$ 112,671	$ 118,608
Work in process	291,028	272,469
Finished goods	113,499	120,716
Total inventories	$ 517,198	$ 511,793

Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019
Property, Plant and Equipment [Abstract]
Land	$ 25,842	$ 25,996
Building and leasehold improvements	404,075	416,209
Machinery and equipment	2,145,511	2,025,110
Property, Plant and Equipment, Gross	2,575,428	2,467,315
Less accumulated depreciation	(1,415,397)	(1,218,507)
Property And Equipment Net Excluding Construction In Progress	1,160,031	1,248,808
Construction in progress	99,172	117,705
Property and equipment, net	$ 1,259,203	$ 1,366,513

Business Acquisitions (Details Textual) - USD ($) $ in Thousands					3 Months Ended				12 Months Ended
	Feb. 21, 2020	Feb. 06, 2020	Oct. 04, 2019	May 06, 2019	Mar. 28, 2020	Dec. 28, 2019	Sep. 28, 2019	Jun. 29, 2019	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018	Oct. 31, 2019
Business Acquisition [Line Items]
Completed and transferred acquired in-process research and development during period									$ 31,000
Integration related costs					$ 24,000	$ 7,200	$ 7,600	$ 23,100
Document Fiscal Year Focus									2020
Remaining research and development costs					2,000				$ 2,000
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain									43,008	$ 0	$ 0
Goodwill, Acquired During Period					2,614,274				2,614,274	2,173,889
Custom MMIC [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross		$ 86,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents		2,300
Business Combination, Net Tangible Assets Acquired		(4,988)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		31,100
Goodwill, Acquired During Period		55,654
Business Combination, Contingent Consideration, Liability, Noncurrent		(5,700)
Business Combination, Consideration Transferred		91,742
Business Combination, Installment Agreement		15,500
Cavendish [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross			$ 198,385
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents			1,800
Business Combination, Net Tangible Assets Acquired			(97)
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value			102,383
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			206,350
Goodwill, Acquired During Period			100,845
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities			(6,524)
Business Combination, Consideration Transferred			300,768
Active-Semi
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents				$ 10,000
Research and Development in Process				40,600
Business Combination, Net Tangible Assets Acquired				(22,876)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill				158,400
Goodwill, Acquired During Period				130,802
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities				(4,184)
Business Combination, Consideration Transferred				307,894
Decawave [Member]
Business Acquisition [Line Items]
Payments to Acquire Businesses, Gross									372,800
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents	$ 5,000
Business Combination, Net Tangible Assets Acquired	(304)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	246,060
Goodwill, Acquired During Period	149,703
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities	(21,327)
Business Combination, Consideration Transferred	374,740
Post-combination consideration	23,100
Mobile Products
Business Acquisition [Line Items]
Goodwill, Acquired During Period					2,005,432				2,005,432	1,751,503
Infrastructure and Defense Products
Business Acquisition [Line Items]
Goodwill, Acquired During Period					608,842				608,842	422,386
Prepaid Expenses and Other Current Assets [Member] \| Decawave [Member]
Business Acquisition [Line Items]
Post-combination consideration									8,100
Other Noncurrent Assets [Member] \| Decawave [Member]
Business Acquisition [Line Items]
Post-combination consideration									9,600
Developed Technology
Business Acquisition [Line Items]
Finite-Lived Intangible Assets, Gross					1,325,472				1,325,472	1,246,335
Developed Technology \| Custom MMIC [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill		$ 26,900
Developed Technology \| Cavendish [Member]
Business Acquisition [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill			$ 206,000
Developed Technology \| Active-Semi
Business Acquisition [Line Items]
Finite-lived Intangible Assets Acquired				76,700
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			9 years
Developed Technology \| Decawave [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		7 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	235,000
Customer Relationships
Business Acquisition [Line Items]
Finite-Lived Intangible Assets, Gross					463,772				463,772	1,272,725
Customer Relationships \| Custom MMIC [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		10 years
Customer Relationships \| Active-Semi
Business Acquisition [Line Items]
Finite-lived Intangible Assets Acquired				$ 40,900
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				5 years
Customer Relationships \| Decawave [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		3 years
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill	10,000
In-process research and development
Business Acquisition [Line Items]
Intangible assets					9,600				9,600	$ 10,000
Minimum \| Developed Technology \| Active-Semi
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				5 years
Minimum \| In-process research and development \| Active-Semi
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				5 years
Maximum \| Custom MMIC [Member]
Business Acquisition [Line Items]
Business Combination, Contingent Consideration, Liability, Noncurrent		$ (10,000)
Maximum \| Developed Technology \| Active-Semi
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				9 years
Maximum \| In-process research and development \| Active-Semi
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				7 years
Other Income [Member] \| Cavendish [Member]
Business Acquisition [Line Items]
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain					$ 43,000	$ 43,000
Other Operating Income (Expense) [Member] \| Custom MMIC [Member]
Business Acquisition [Line Items]
Integration related costs									9,400
Other Operating Income (Expense) [Member] \| Cavendish [Member]
Business Acquisition [Line Items]
Integration related costs									3,800
Other Operating Income (Expense) [Member] \| Active-Semi
Business Acquisition [Line Items]
Integration related costs									25,300
Other Operating Income (Expense) [Member] \| Decawave [Member]
Business Acquisition [Line Items]
Integration related costs	$ 7,000
Post-combination consideration									5,400
Cost of Sales [Member] \| Active-Semi
Business Acquisition [Line Items]
Business Combination, Acquisition And Integration related costs									$ 4,200
Cavendish [Member]
Business Acquisition [Line Items]
Equity Securities without Readily Determinable Fair Value, Amount							$ 59,400
October 2019 Program [Member]
Business Acquisition [Line Items]
Stock Repurchase Program, Authorized Amount												$ 1,000,000

Goodwill and Intangible Assets (Details 1) - USD ($) $ in Thousands			12 Months Ended
	Feb. 21, 2020	Oct. 04, 2019	Mar. 28, 2020	Mar. 30, 2019
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period	$ 149,703
Document Period End Date			Mar. 28, 2020
Gross carrying amounts and amortization of intangibles
Accumulated Amortization			$ 1,002,087	$ 2,165,971
Finite-Lived and Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)			6,064	0
Finite-Lived and Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Amortization			11	0
Goodwill, Foreign Currency Translation Gain (Loss)			3,381
Gross Carrying Amount			1,810,979	2,574,181
Technology licenses
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			3,271	14,704
Accumulated Amortization			2,327	13,026
Backlog [Member]
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			1,600	0
Accumulated Amortization			267	0
Noncompete Agreements [Member]
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			0	1,026
Accumulated Amortization			0	1,026
Customer Relationships
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			463,772	1,272,725
Accumulated Amortization			346,799	1,161,735
Developed Technology
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			1,325,472	1,246,335
Accumulated Amortization			652,400	960,793
Trade Names
Gross carrying amounts and amortization of intangibles
Gross Carrying Amount			1,200	29,391
Accumulated Amortization			283	$ 29,391
Active-Semi
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period			130,802
Cavendish [Member]
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		$ 100,845
Infrastructure and Defense Products \| Active-Semi
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period			130,802
Mobile Products
Gross carrying amounts and amortization of intangibles
Goodwill, Foreign Currency Translation Gain (Loss)			$ 3,381
Mobile Products \| Decawave [Member]
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period	$ 149,703
Mobile Products \| Cavendish [Member]
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		$ 100,845

Goodwill and Intangible Assets (Details 2) $ in Thousands	Mar. 28, 2020 USD ($)
Estimated Amortization Expense
2021	$ 119,000
2022	103,000
2023	90,000
2024	76,000
2025	$ 248,000

Goodwill and Intangible Assets (Details 3) - USD ($) $ in Thousands	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Goodwill and Intangible Assets [Line Items]
Intangible assets amortization	$ 247,299	$ 454,451	$ 539,790

Goodwill and Intangible Assets (Details Textual) - USD ($) $ in Thousands			12 Months Ended
	Feb. 21, 2020	Feb. 06, 2020	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Goodwill and Intangible Assets [Line Items]
Goodwill			$ 2,614,274	$ 2,173,889
Goodwill, Acquired During Period	$ 149,703
Accumulated impairment losses and write-offs			621,600	621,600
Amortization of Intangible Assets			247,299	454,451	$ 539,790
In-process research and development
Goodwill and Intangible Assets [Line Items]
IPRD			9,600	10,000
Custom MMIC [Member]
Goodwill and Intangible Assets [Line Items]
Goodwill		$ 55,654
Goodwill, Acquired During Period		$ 55,654
Custom MMIC [Member] \| Customer Relationships
Goodwill and Intangible Assets [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		10 years
Mobile Products
Goodwill and Intangible Assets [Line Items]
Goodwill			2,005,432	1,751,503
Infrastructure and Defense Products
Goodwill and Intangible Assets [Line Items]
Goodwill			$ 608,842	$ 422,386
Infrastructure and Defense Products \| Custom MMIC [Member]
Goodwill and Intangible Assets [Line Items]
Goodwill, Acquired During Period		$ 55,654

Investments and Fair Value Measurements (Details) - USD ($) $ in Thousands	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Schedule of available-for-sale debt securities
Cost-method Investments, Other than Temporary Impairment	$ 18,339	$ 0	$ 0

Investments and Fair Value Measurements (Details 2) - USD ($) $ in Thousands	Mar. 28, 2020	Feb. 06, 2020	Mar. 30, 2019
Recurring
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	$ 19,398		$ 18,737
Total assets measured at fair value	19,857		21,601
Deferred compensation plan liability	19,398		18,737
Business Combination, Contingent Consideration, Liability, Noncurrent	5,700
Money Market Funds, at Carrying Value			13
Total liabilities measured at fair value	25,098		18,737
Recurring \| Quoted Prices In Active Markets For Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	19,398		18,737
Total assets measured at fair value	19,857		19,651
Deferred compensation plan liability	19,398		18,737
Business Combination, Contingent Consideration, Liability, Noncurrent	0
Total liabilities measured at fair value	19,398		18,737
Recurring \| Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	0		0
Total assets measured at fair value	0		1,950
Deferred compensation plan liability	0		0
Business Combination, Contingent Consideration, Liability, Noncurrent	0
Total liabilities measured at fair value	0		0
Recurring \| Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Deferred compensation plan assets	0		0
Total assets measured at fair value	0		0
Deferred compensation plan liability	0
Business Combination, Contingent Consideration, Liability, Noncurrent	5,700
Auction rate securities \| Recurring
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Debt Securities, Available-for-sale			1,950
Auction rate securities \| Recurring \| Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Debt Securities, Available-for-sale			1,950
Auction rate securities \| Recurring \| Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Debt Securities, Available-for-sale			0
Money market funds \| Recurring \| Quoted Prices In Active Markets For Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Money Market Funds, at Carrying Value			13
Money market funds \| Recurring \| Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Money Market Funds, at Carrying Value			0
Money market funds \| Recurring \| Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Money Market Funds, at Carrying Value			0
Equity Securities \| Recurring
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	459		901
Equity Securities \| Recurring \| Quoted Prices In Active Markets For Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	459		901
Equity Securities \| Recurring \| Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	0		0
Equity Securities \| Recurring \| Fair Value, Inputs, Level 3
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Marketable Securities	$ 0		$ 0
Custom MMIC [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Line Items]
Business Combination, Contingent Consideration, Liability, Noncurrent		$ 5,700

Investments and Fair Value Measurements (Details Textual) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019
Fair Value, Inputs, Level 3
Schedule of available-for-sale debt securities
Available-for-sale Securities	$ 0	$ 0

Leases (Details) - USD ($) $ in Thousands	12 Months Ended
Leases (Details) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Lessee, Lease, Description [Line Items]
Lessee, Finance Lease, Term of Contract	5 years
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months		$ 22,207
Finance Lease, Liability, Payment, Due	$ 56,200
Document Period End Date	Mar. 28, 2020
Operating lease expense	$ 15,184	19,300	$ 16,300
Short-term lease expense	6,878
Variable lease expense	3,098
Operating Leases, Future Minimum Payments, Due in Two Years		13,382
Operating Leases, Future Minimum Payments, Due in Three Years		10,331
Operating Leases, Future Minimum Payments, Due in Four Years		8,224
Operating Leases, Future Minimum Payments, Due in Five Years		7,139
Operating Leases, Future Minimum Payments, Due Thereafter		31,598
Operating Leases, Future Minimum Payments Due		$ 92,881
Operating Lease, Payments	16,504
Operating lease assets obtained in exchange for new lease liabilities	$ 13,201
Maximum
Lessee, Lease, Description [Line Items]
Lessee, Finance Lease, Term of Contract	30 years

Leases Supplemental balance sheet information (Details) $ in Thousands	Mar. 28, 2020 USD ($)
Leases [Abstract]
Operating lease asset	$ 65,107
Current operating lease liability	15,917
Non-current operating lease liability	$ 58,077

Leases Weighted average remaining lease term and discount rate (Details)	Mar. 28, 2020
Leases [Abstract]
Weighted-average remaining lease term (years) - operating leases	7 years 9 months 18 days
Weighted-average discount rate - operating leases	4.06%

Leases Schedule of lease maturities (Details) $ in Thousands	Mar. 28, 2020 USD ($)
Leases [Abstract]
2021	$ 21,586
2022	14,201
2023	9,690
2024	7,449
2025	6,006
Thereafter	27,194
Total lease payments	86,126
Less imputed interest	(12,132)
Present value of lease liabilities	$ 73,994

Debt (Details) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019	Dec. 05, 2017
Debt Instrument [Line Items]
Total long-term debt	$ 1,567,231	$ 920,935
Term Loan [Member]
Debt Instrument [Line Items]
Total long-term debt	100,000	0
7.00% Senior Notes due 2025
Debt Instrument [Line Items]
Total long-term debt	23,404	23,404
5.5% Senior Notes due 2026
Debt Instrument [Line Items]
Total long-term debt	900,000	900,000
Senior Notes Due 2029 4.375% [Member]
Debt Instrument [Line Items]
Total long-term debt	550,000	0
Finance leases [Member]
Debt Instrument [Line Items]
Total long-term debt	$ 2,252	$ 1,745
Revolving Credit Facility \| Credit Agreement [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum amount of increase that may be requested			$ 300,000

Debt (Details Textual) - USD ($) $ in Thousands				3 Months Ended				12 Months Ended
Debt (Details Textual) - USD ($) $ in Thousands	Jun. 17, 2019	Jul. 16, 2018	Dec. 05, 2017	Mar. 30, 2019	Dec. 29, 2018	Sep. 29, 2018	Jun. 30, 2018	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018	Dec. 31, 2019	Dec. 20, 2019	Sep. 30, 2019	Mar. 05, 2019	Aug. 28, 2018	Nov. 19, 2015
Debt Instrument [Line Items]
Long-term Debt, Current Maturities				$ 80				$ 6,893	$ 80
Document Fiscal Year Focus								2020
Net carrying amount of debt				920,935				$ 1,567,231	920,935
Interest Expense, Debt								66,000	52,800	$ 73,200
Gain (Loss) on Extinguishment of Debt				(6,200)	$ (1,800)	$ (48,800)	$ (33,400)	0	(90,201)	(928)
Unamortized premium and issuance costs, net				4,134				1,532	4,134
Senior Notes
Debt Instrument [Line Items]
Interest Costs Capitalized								$ 5,600	8,800	13,600
6.75% Senior Notes due 2023
Debt Instrument [Line Items]
Debt Instrument, Face Amount																$ 450,000
Debt Instrument, Interest Rate, Stated Percentage								6.75%
7.00% Senior Notes due 2025
Debt Instrument [Line Items]
Debt Instrument, Face Amount																$ 550,000
Debt Instrument, Interest Rate, Stated Percentage								7.00%
Repayments of Senior Debt									526,600
Interest paid								$ 1,600
Long-term Debt, Fair Value				25,800				23,900	25,800
Net carrying amount of debt				23,404				$ 23,404	23,404
6.75% Senior Notes due 2023 and 7.00% Senior Notes due 2025 [Member]
Debt Instrument [Line Items]
Interest paid									46,500	$ 68,900
5.5% Senior Notes due 2026
Debt Instrument [Line Items]
Debt Instrument, Face Amount		$ 500,000												$ 270,000	$ 130,000
Debt Instrument, Interest Rate, Stated Percentage		5.50%						5.50%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed		35.00%
Debt Instrument, Redemption Price, Percentage		105.50%
Interest paid								$ 49,500	17,200
Long-term Debt, Fair Value				929,300				962,800	929,300
Net carrying amount of debt				900,000				900,000	900,000
Senior Notes Due 2029 4.375% [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount												$ 200,000	$ 350,000
Debt Instrument, Interest Rate, Stated Percentage													4.375%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed		35.00%
Debt Instrument, Redemption Price, Percentage		104.375%
Debt, Interest Rate, Default Increase, Percentage													0.25%
Long-term Debt, Fair Value								489,500
Net carrying amount of debt				$ 0				$ 550,000	0
Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Consolidated Total Leverage Ratio Allowed								3.0
Permitted acquisition amount for increase in leverage ratio								$ 300,000
Line of credit facility, maximum consolidated total leverage ratio allowed, with permitted acquisition								3.5
Line of Credit Facility, Minimum Consolidated Interest Coverage Ratio Required								3.0
Revolving Credit Facility \| Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 300,000
Line of Credit Facility, Maximum amount of increase that may be requested			300,000
Senior Delayed Draw Term Loan \| Credit Agreement
Debt Instrument [Line Items]
Senior Delayed Draw Term Loan, Maximum Amount			400,000
Interest paid								$ 2,400
Proceeds from borrowings and debt issuances (Note 9)			100,000
Line of Credit Facility, Remaining Borrowing Capacity											$ 200,000
Standby Letters of Credit \| Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			25,000
Swingline Loan \| Credit Agreement
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity			$ 10,000
Federal Funds Rate \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate								0.50%
Eurodollar \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate								1.00%
Bank of America Syndicate [Member] \| Senior Delayed Draw Term Loan \| Credit Agreement
Debt Instrument [Line Items]
Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months								$ 6,250
Proceeds from borrowings and debt issuances (Note 9)	$ 100,000
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two								5,000
Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three								88,750
Unsecured Debt								$ 100,000
Maximum \| Senior Notes Due 2029 4.375% [Member]
Debt Instrument [Line Items]
Debt, Interest Rate, Default Increase, Percentage													1.00%
Maximum \| Eurodollar \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								1.375%
Maximum \| Base Rate \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								0.375%
Minimum \| Eurodollar \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								1.125%
Minimum \| Base Rate \| Credit Agreement
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage								0.125%
Other Expense [Member] \| 6.75% Senior Notes due 2023
Debt Instrument [Line Items]
Gain (Loss) on Extinguishment of Debt									$ 90,200

Retirement Benefit Plans (Details) $ in Millions	12 Months Ended
Retirement Benefit Plans (Details) $ in Millions	Mar. 28, 2020 USD ($)	Mar. 30, 2019 USD ($)	Mar. 31, 2018 USD ($)
U. S. Defined Contribution Plan [Member]
Retirement Benefit Plan (Textual)
Defined Contribution Plan, Company Contribution Amount	$ 14.4	$ 14.0	$ 14.0
Non-Qualified Deferred Compensation Plan [Member]
Retirement Benefit Plan (Textual)
Assets held in rabbi trust	19.4	18.7
Assets held in rabbi trust, current	0.9	1.1
Assets held in rabbi trust, noncurrent	18.5	17.6
Foreign Plan [Member]
Retirement Benefit Plan (Textual)
Defined benefit plan insurance receivable	3.6
Defined Benefit Pension Plan, Benefit Obligation	12.3	12.9
Defined Benefit Pension Plan, Net Periodic Benefit Cost	$ 0.6	$ 0.5	$ 0.7
Number of retirement benefit plans offered by the Company	2

Commitments and Contingent Liabilities (Details) $ in Millions	Mar. 28, 2020 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Purchase Obligation	$ 318.3

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
Restructuring (Details) - USD ($) $ in Thousands	Mar. 28, 2020	Dec. 28, 2019	Sep. 28, 2019	Jun. 29, 2019	Mar. 30, 2019	Dec. 29, 2018	Sep. 29, 2018	Jun. 30, 2018	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Restructuring Cost and Reserve [Line Items]
Document Fiscal Year Focus									2020
Payments for Restructuring									$ (18,811)	$ (13,540)
Asset Impairment Charges									1,057	15,901	$ 46,315
Restructuring related charges	$ 4,100	$ 10,300	$ 9,500	$ 24,000	$ 27,900	$ 19,500	$ 500	$ 2,800	47,869	50,714	67,721
Restructuring obligations	1,998				8,614				1,998	8,614	8,687
Transfer to right-of-use asset									(1,248)
Restructuring Reserve, Non-Cash Activity									$ (34,426)	(37,247)
Document Period End Date									Mar. 28, 2020
Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring									$ 0	0
Restructuring related charges									26,061	37,247
Restructuring obligations	0				0				0	0	0
Transfer to right-of-use asset									0
Restructuring Reserve, Non-Cash Activity									(26,061)	(37,247)
Business combination
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									300	1,300	2,700
One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring									(11,549)	(11,968)
Restructuring related charges									6,289	12,826	19,232
Restructuring obligations	1,728				6,988				1,728	6,988	6,130
Transfer to right-of-use asset									0
Restructuring Reserve, Non-Cash Activity									0	0
Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Payments for Restructuring									(7,262)	(1,572)
Restructuring related charges									15,519	641	2,174
Restructuring obligations	270				$ 1,626				270	1,626	2,557
Transfer to right-of-use asset									(1,248)
Restructuring Reserve, Non-Cash Activity									(8,365)	0
Impairment charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges											46,315
Accelerated Depreciation and Impairment Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges										37,247
Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									34,426	21,346	0
Cost of sales \| Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									26,061
Cost of sales \| One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									0	0	0
Cost of sales \| Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									8,365	0	0
Cost of sales \| Impairment charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges											0
Cost of sales \| Accelerated Depreciation and Impairment Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges										21,346
Other operating expense
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									13,443	29,368	67,721
Other operating expense \| Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									0
Other operating expense \| One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									6,289	12,826	19,232
Other operating expense \| Contract Termination [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges									7,154	641	2,174
Other operating expense \| Impairment charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges											$ 46,315
Other operating expense \| Accelerated Depreciation and Impairment Charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring related charges										$ 15,901
Fiscal Year 2019
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	92,000								92,000
Fiscal Year 2019 \| Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	47,400								47,400
Fiscal Year 2019 \| One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	13,700								13,700
Restructuring and Related Cost, Expected Cost Remaining	1,000								1,000
Fiscal Year 2019 \| Other restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	15,000								15,000
Fiscal Year 2019 \| Impairment charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	15,900								15,900
Fiscal Year 2018 \| One-time termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	23,500								23,500
Fiscal Year 2018 \| Other restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	200								200
Fiscal Year 2018 \| Impairment charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date	$ 46,300								$ 46,300

Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Income (loss) before income taxes
United States	$ (226,005)	$ (297,975)	$ (151,083)
Foreign	621,094	389,767	168,228
Income before income taxes	$ 395,089	$ 91,792	$ 17,145

Income Taxes (Details 1) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
Income Taxes (Details 1) - USD ($) $ in Thousands	Mar. 30, 2019	Jun. 30, 2018	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Current (expense) benefit:
Federal			$ (6,705)	$ 17,222	$ (28,168)
State			(93)	209	(229)
Foreign			(65,065)	(46,267)	(61,284)
Total current (expense) benefit			(71,863)	(28,836)	(89,681)
Deferred (expense) benefit:
Federal			7,826	55,833	11,817
State			4,603	946	253
Foreign			(1,330)	13,390	20,178
Total deferred (expense) benefit			11,099	70,169	32,248
Income tax expense (benefit)	$ (11,300)	$ (32,100)	$ 60,764	$ (41,333)	$ 57,433

Income Taxes (Details 2) - USD ($)	3 Months Ended		12 Months Ended
Income Taxes (Details 2) - USD ($)	Mar. 30, 2019	Jun. 30, 2018	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
ReconciliationOfProvisionOfIncomeTaxes [Line Items]
Document Fiscal Year Focus			2020
Deferred Income Tax Expense (Benefit)			$ (11,099,000)	$ (70,169,000)	$ (32,248,000)
Income tax expense at statutory federal rate			$ (82,969,000)	$ (19,276,000)	$ (5,407,000)
Income tax expense at statutory federal rate, Percentage			21.00%	21.00%	31.50%
Decrease (increase) resulting from:
State benefit (provision), net of federal (provision) benefit			$ 2,605,000	$ 710,000	$ 474,000
State benefit (provision), net of federal (provision) benefit, Percentage			(0.70%)	(0.80%)	(2.80%)
Effective Income Tax Rate Reconciliation, Tax Credit, Amount			$ 64,017,000	$ 69,856,000	$ 38,054,000
Effective Income Tax Rate Reconciliation, Tax Credit, Percent			16.20%	76.10%	221.90%
Effect of changes in income tax rate applied to net deferred tax assets			$ (2,269,000)	$ 12,972,000	$ 39,168,000
Effect of changes in income tax rate applied to net deferred tax assets, Percentage			0.60%	(14.10%)	(228.40%)
Foreign tax rate difference			$ 75,247,000	$ 41,672,000	$ 21,829,000
Foreign tax rate difference, Percentage			(19.00%)	(45.40%)	(127.30%)
Foreign permanent differences, amount			$ (5,446,000)	$ 6,825,000	$ (2,598,000)
Foreign permanent differences, percent			1.40%	(7.40%)	15.20%
Change in valuation allowance			$ 6,438,000	$ 2,353,000	$ (1,632,000)
Change in valuation allowance, Percentage			(1.60%)	(2.60%)	9.50%
Effective income tax rate reconciliation, expiration of state attributes, amount			$ 5,165,000	$ 0	$ 0
Effective income tax rate reconciliation, expiration of state attributes, percent			1.30%	0.00%	0.00%
Stock-based compensation			$ (1,707,000)	$ (7,694,000)	$ 9,924,000
Share-based compensation, Percentage			0.40%	8.40%	(57.90%)
Tax reserve adjustments			$ (13,973,000)	$ 5,213,000	$ (29,188,000)
Tax reserve adjustments, Percentage			3.50%	(5.70%)	170.20%
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount			$ 81,916,000	$ 76,215,000	$ 5,098,000
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent			20.80%	83.00%	29.70%
U.S. Tax Toll Charge			$ 0	$ 1,897,000	$ (116,419,000)
U.S. Tax Toll Charge, Percent			0.00%	(2.10%)	679.00%
Intra-entity transfer			$ 0	$ 3,935,000	$ (6,873,000)
Intra-entity transfer, percent			0.00%	(4.30%)	40.10%
Effective income tax rate reconciliation, permanent reinvestment assertion, amount			$ (6,814,000)	$ 0	$ 0
Effective income tax rate reconciliation, permanent reinvestment assertion, percent			1.70%	0.00%	0.00%
Effective income tax rate reconciliation, Acquisition related adjustments, amount			$ (7,257,000)	$ 0	$ 0
Effective income tax rate reconciliation, Acquisition related adjustments, percent			1.80%	0.00%	0.00%
Other income tax benefit (expense)			$ (1,555,000)	$ (915,000)	$ 333,000
Other income tax benefit (expense), Percentage			0.40%	1.10%	(1.90%)
Income tax expense (benefit)	$ (11,300,000)	$ (32,100,000)	$ 60,764,000	$ (41,333,000)	$ 57,433,000
Total, Percentage			15.40%	(45.00%)	335.00%

Income Taxes (Details 3) - USD ($)	Mar. 28, 2020	Mar. 30, 2019
Deferred income tax assets:
Inventory reserve	$ 10,114,000	$ 8,588,000
Equity compensation	18,817,000	27,380,000
Net operating loss carry-forwards	71,928,000	13,744,000
Research and other credits	106,958,000	95,640,000
Employee benefits	12,606,000	13,070,000
Lease liabilities	16,456,000	0
Other deferred assets	3,559,000	19,457,000
Total deferred income tax assets	240,438,000	177,879,000
Valuation allowance	(35,280,000)	(40,433,000)
Total deferred income tax assets, net of valuation allowance	205,158,000	137,446,000
Deferred income tax liabilities:
Amortization and purchase accounting basis difference	(107,517,000)	(45,665,000)
Accumulated depreciation/basis difference	(59,356,000)	(62,097,000)
Accrued tax on unremitted foreign earnings	(15,521,000)	0
Right-of-use assets	(14,400,000)	0
Other deferred liabilities	1,955,000	0
Total deferred income tax liabilities	(198,749,000)	(107,762,000)
Deferred Tax Assets, Net	6,409,000	29,684,000
Amounts included in consolidated balance sheets:
Other non-current assets	45,754,000	30,017,000
Other long-term liabilities	$ 39,345,000	$ 333,000

Income Taxes (Details 4) - USD ($) $ in Thousands	12 Months Ended
Income Taxes (Details 4) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Reconciliation of gross unrecognized tax benefits
Beginning balance	$ 103,178	$ 122,823	$ 90,615
Additions based on positions related to current year	10,357	7,193	26,431
Additions for tax positions in prior years	6,484	8,369	5,844
Reductions for tax positions in prior years	(69)	(24,932)	(67)
Expiration of statute of limitations	(728)	(6,972)	0
Settlements	0	(3,303)	0
Ending balance	$ 119,222	$ 103,178	$ 122,823

Income Taxes (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 30, 2019	Jun. 30, 2018	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018	Apr. 01, 2017
Income Taxes (Textual)
Valuation Allowance	$ 40,433		$ 35,280	$ 40,433
Valuation Allowance, Deferred Tax Asset, Change in Amount			$ 5,200	2,400	$ (9,700)
Years elected to pay Transitional Repatriation Tax			8 years
Loss carryovers			$ 397,500
Foreign jurisdiction exemption reduction, Dollar Amount			62,900	34,600
Gross unrecognized tax benefits	103,178		119,222	103,178	122,823	$ 90,615
Unrecognized tax benefits, if recognized, would impact the effective tax rate	99,100		114,800	99,100	118,700
Interest and penalties expense (benefit) recognized related to uncertain tax positions			(700)	200	2,500
Accrued interest and penalties related to unrecognized tax benefits	4,400		5,400	4,400	4,600
Long-term Tax Liability			$ 19,400
Period gross unrecognized tax benefits may be reduced			12 months
Taxes Payable, Current	41,600		$ 50,800	41,600
Income Taxes Receivable, Current	6,200		5,400	6,200
Long-term income taxes payable	5,700		5,600	5,700
Income tax expense (benefit)	(11,300)	$ (32,100)	60,764	(41,333)	57,433
Deferred Income Tax Expense (Benefit)			(11,099)	(70,169)	(32,248)
Tax settlement			0	3,303	0
Unrecognized Tax Benefits, Increase Resulting from Acquisition			7,500
Domestic deferred tax assets
Income Taxes (Textual)
Valuation Allowance	39,300		31,500	39,300	40,800
Tax rate changes [Member]
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount					(6,800)
Foreign deferred tax assets
Income Taxes (Textual)
Valuation Allowance	$ 1,100		3,800	1,100	2,000
Valuation Allowance, Deferred Tax Asset, Change in Amount					(500)
State net operating losses and credits
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount			7,900	1,500	(1,900)
Foreign net operating losses
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount			(2,700)	$ 900	(1,000)
Valuation Allowance, Deferred Tax Asset, Increase (Decrease) due to purchase accounting adjustments, Amount			2,100
State tax credits [Member]
Income Taxes (Textual)
Valuation Allowance, Deferred Tax Asset, Change in Amount					(500)
U.S. Tax Cuts and Jobs Act, Effective 2018 [Member]
Income Taxes (Textual)
Income tax expense (benefit)					77,300
Measurement period adjustment, income tax expense (benefit)					$ 17,000
U.S. Federal
Income Taxes (Textual)
Loss carryovers			190,400
State
Income Taxes (Textual)
Loss carryovers			281,100
Research Tax Credit Carryforward [Member]
Income Taxes (Textual)
Income tax credits			143,000
Foreign deferred tax assets
Income Taxes (Textual)
Loss carryovers			107,500
State
Income Taxes (Textual)
Income tax credits			$ 64,100
Basic
Income Taxes (Textual)
Foreign jurisdiction exemption reduction, per share amount			$ 0.54	$ 0.28
Diluted
Income Taxes (Textual)
Foreign jurisdiction exemption reduction, per share amount			$ 0.53	$ 0.27

Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 28, 2020	Dec. 28, 2019	Sep. 28, 2019	Jun. 29, 2019	Mar. 30, 2019	Dec. 29, 2018	Sep. 29, 2018	Jun. 30, 2018	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Numerator:
Numerator for basic and diluted net (loss) income per share - net (loss) income available to common stockholders	$ 50,390	$ 161,356	$ 83,038	$ 39,541	$ 61,517	$ 69,517	$ 32,084	$ (29,993)	$ 334,325	$ 133,125	$ (40,288)
Denominator:
Denominator for basic net (loss) income per share — weighted average shares									117,007	124,534	126,946
Effect of dilutive securities:
Stock-based awards									2,286	2,822	0
Denominator for diluted net (loss) income per share — adjusted weighted average shares and assumed conversions									119,293	127,356	126,946
Basic net (loss) income per share	$ 0.44	$ 1.39	$ 0.71	$ 0.33	$ 0.51	$ 0.56	$ 0.26	$ (0.24)	$ 2.86	$ 1.07	$ (0.32)
Diluted net (loss) income per share	$ 0.43	$ 1.36	$ 0.70	$ 0.33	$ 0.50	$ 0.55	$ 0.25	$ (0.24)	$ 2.80	$ 1.05	$ (0.32)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Net Income (Loss) Per Share (Details Textual) - shares shares in Millions	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Earnings Per Share [Abstract]
Shares excluded from the computation of diluted shares outstanding	0.1	0.3	3.7

Stock-Based Compensation (Details) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 28, 2020 USD ($) $ / shares shares
Summary of activity of the Company's director and employee stock option plans
Outstanding beginning balance, Shares \| shares	1,886
Outstanding beginning balance, Weighted-Average Exercise Price \| $ / shares	$ 20.36
Granted, Shares \| shares	0
Granted, Weighted-Average Exercise Price \| $ / shares	$ 0
Exercised, Shares \| shares	(917)
Exercised, Weighted-Average Exercise Price \| $ / shares	$ 22.70
Canceled, Shares \| shares	(2)
Canceled, Weighted-Average Exercise Price \| $ / shares	$ 30.84
Forfeited, Shares \| shares	0
Forfeited, Weighted-Average Exercise Price \| $ / shares	$ 0
Outstanding ending balance, Shares \| shares	967
Outstanding ending balance, Weighted-Average Exercise Price \| $ / shares	$ 18.11
Outstanding ending balance, Weighted-Average Remaining Contractual Term	2 years 4 months 13 days
Outstanding ending balance, Aggregate Intrinsic Value \| $	$ 60,529
Vested and expected to vest, Shares \| shares	967
Vested and expected to vest, Weighted-Average Exercise Price \| $ / shares	$ 18.11
Vested and expected to vest, Weighted-Average Remaining Contractual Term	2 years 4 months 13 days
Vested and expected to vest, Aggregate Intrinsic Value \| $	$ 60,529
Options exercisable, Shares \| shares	967
Options exercisable, Weighted-Average Exercise Price Ending Balance \| $ / shares	$ 18.11
Options exercisable, Weighted-Average Remaining Contractual Term Ending Balance	2 years 4 months 13 days
Options exercisable, Aggregate Intrinsic Value \| $	$ 60,529

Stock-Based Compensation (Details 2) shares in Thousands	12 Months Ended
Stock-Based Compensation (Details 2) shares in Thousands	Mar. 28, 2020 $ / shares shares
Restricted share plans
Balance at beginning balance, Shares \| shares	1,994
Balance at beginning balance, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 69.03
Granted, Shares \| shares	1,146
Granted, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 71.88
Vested, Shares \| shares	(936)
Vested, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 64.89
Forfeited, Shares \| shares	(113)
Forfeited, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 69.76
Balance at ending balance, Shares \| shares	2,091
Balance at ending balance, Weighted-Average Grant-Date Fair Value \| $ / shares	$ 72.59

Stock-Based Compensation (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018	Apr. 01, 2006
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	4,515,000
Document Fiscal Year Focus	2020
Shares granted	0
Stock-based compensation expense	$ 75,978	$ 71,580	$ 68,158
Closing stock price	$ 80.69
Total intrinsic value of options exercised	$ 65,100	37,900	87,800
Cash received from the exercise of stock options (excluding accrued unremitted employee funds)	$ 49,500
Annual forfeiture rate	1.40%
Total fair value of vested restricted stock units	$ 67,700	$ 77,500	$ 73,200
Certain officers of the Company (Section 16 Officers)
Share-Based Compensation (Textual)
Shares granted	300,000
Stock-based compensation expense	$ 24,100
Employee Stock Purchase Plan
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	3,700,000
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	85.00%
Period employees can acquire common stock	6 months
Shares issued under plan	500,000
2006 Directors' Stock Option Plan
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	0
Reserved additional shares of common stock				300,000
2009 and 2012 Incentive Plans - TriQuint
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	0
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	100.00%
Expected term (in years)	10 years
2013 Incentive Plan - Qorvo
Share-Based Compensation (Textual)
Number of shares available for grant or issuance		1,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Percent of Market Price	100.00%
Expected term (in years)	10 years
2015 Inducement Stock Plan - Qorvo
Share-Based Compensation (Textual)
Number of shares available for grant or issuance		300,000
Maximum number of shares of common stock to be issued under plan	300,000
Shares granted	0	0	0
2012 Stock Incentive Plan - Qorvo
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	2,900,000
Maximum number of shares of common stock to be issued under plan	4,300,000
2003 Stock Incentive Plan - RF Micro Devices
Share-Based Compensation (Textual)
Number of shares available for grant or issuance	0
Performance-based restricted stock \| 2012 Stock Incentive Plan - Qorvo
Share-Based Compensation (Textual)
Shares granted	200,000
Restricted Stock
Share-Based Compensation (Textual)
Vesting period	4 years
Total remaining unearned compensation cost related to nonvested restricted stock unit	$ 87,400
Weighted-average remaining service period of unearned compensation costs related to nonvested restricted stock units	1 year 3 months 18 days
Performance and service-based restricted stock units
Share-Based Compensation (Textual)
Vesting percentage when earned	50.00%
Vesting period	2 years
performance period 1 [Member]
Share-Based Compensation (Textual)
Vesting period	1 year
performance period 2 [Member]
Share-Based Compensation (Textual)
Vesting period	2 years
performance period 3 [Member]
Share-Based Compensation (Textual)
Vesting period	3 years

Stockholders' Equity (Details) - shares shares in Thousands	Mar. 28, 2020	Mar. 30, 2019
Common stock reserved for future issuance
Outstanding stock options under formal directors’ and employees’ stock option plans	967	1,886
Possible future issuance under Company stock incentive plans	4,515
Employee stock purchase plan	3,673
Restricted stock-based units granted	2,091	1,994
Total shares reserved	11,246

Stockholders' Equity (Details Textual) - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018	Oct. 31, 2019
Shareholders' Equity (Textual)
Stock Repurchased During Period, Shares	(6,441)	(9,095)	(2,929)
Document Fiscal Year Focus	2020
Stock Repurchased During Period, Value	$ 515,131	$ 638,074	$ 219,907
Document Period End Date	Mar. 28, 2020
Common stock reserved for future issuance	11,246
Common stock, shares authorized	405,000	405,000
May 2018 Program
Shareholders' Equity (Textual)
Stock Repurchase Program, Remaining Authorized Repurchase Amount				$ 117,000
October 2019 Program [Member]
Shareholders' Equity (Textual)
Share repurchase program, authorized amount				$ 1,000,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 765,900
Common Stock [Member]
Shareholders' Equity (Textual)
Stock Repurchased During Period, Value	$ 501,868	$ 638,074	$ 219,907

Operating Segment and Geographical Information (Details) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Mar. 28, 2020

Dec. 28, 2019

Sep. 28, 2019

Jun. 29, 2019

Mar. 30, 2019

Dec. 29, 2018

Sep. 29, 2018

Jun. 30, 2018

Mar. 28, 2020

Mar. 30, 2019

Mar. 31, 2018

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Document Fiscal Year Focus

2020

Revenue:

Revenues

$ 787,772

$ 869,073

$ 806,698

$ 775,598

$ 680,882

$ 832,330

$ 884,443

$ 692,670

$ 3,239,141

$ 3,090,325

$ 2,973,536

Income from operations:

Operating income

423,216

216,466

70,282

Interest expense

(60,392)

(43,963)

(59,548)

Interest income

12,066

10,971

7,017

Other income (expense)

20,199

(91,682)

(606)

(Loss) income before income taxes

395,089

91,792

17,145

Operating Segments [Member] | MP [Member]

Revenue:

Revenues

2,397,740

2,197,660

2,181,161

Income from operations:

Operating income

715,514

558,990

549,574

Operating Segments [Member] | IDP [Member]

Revenue:

Revenues

841,401

892,665

788,495

Income from operations:

Operating income

145,295

267,304

235,719

All other

Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]

Asset Impairment and Accelerated Depreciation

27,118

37,246

38,000

Revenue:

Revenues

3,880

^[1]

Income from operations:

Operating income

$ (437,593)

$ (609,828)

$ (715,011)

[1]

"All other" revenue relates to royalty income that was not allocated to MP or IDP for fiscal 2018. As a result of the adoption of ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)," income related to a right-to-use license of intellectual property was recognized at a point-in-time and, therefore, was included as a transition adjustment impacting retained earnings.

Operating Segment and Geographical Information (Details 1) - USD ($) $ in Thousands	3 Months Ended						12 Months Ended
	Mar. 28, 2020	Dec. 28, 2019	Jun. 29, 2019	Dec. 29, 2018	Sep. 29, 2018	Jun. 30, 2018	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Segment Reporting Information [Line Items]
Document Fiscal Year Focus							2020
Reconciliation of "All other" category:
Stock-based compensation expense							$ (75,978)	$ (71,580)	$ (68,158)
Amortization of intangible assets							(247,299)	(454,451)	(539,790)
Start-up costs	$ (200)	$ (400)	$ (100)	$ (6,800)	$ (5,900)	$ (5,300)
Operating income							423,216	216,466	70,282
All other
Reconciliation of "All other" category:
Stock-based compensation expense							(75,978)	(71,580)	(68,158)
Amortization of intangible assets							(246,563)	(453,515)	(539,362)
Acquisition and integration related costs							(61,891)	(8,522)	(10,561)
Restructuring and disposal costs							(21,808)	(13,467)	(21,406)
Start-up costs							(712)	(18,035)	(24,271)
Asset Impairment and Accelerated Depreciation							27,118	37,246	38,000
Other (including (loss) gain on assets and other miscellaneous corporate overhead)							(3,523)	(7,463)	(13,253)
Operating income							$ (437,593)	$ (609,828)	$ (715,011)

Operating Segment and Geographical Information (Details 2) - USD ($)
$ in Thousands

3 Months Ended

12 Months Ended

Mar. 28, 2020

Dec. 28, 2019

Sep. 28, 2019

Jun. 29, 2019

Mar. 30, 2019

Dec. 29, 2018

Sep. 29, 2018

Jun. 30, 2018

Mar. 28, 2020

Mar. 30, 2019

Mar. 31, 2018

Revenues from External Customers [Line Items]

Document Fiscal Year Focus

2020

Revenues

$ 787,772

$ 869,073

$ 806,698

$ 775,598

$ 680,882

$ 832,330

$ 884,443

$ 692,670

$ 3,239,141

$ 3,090,325

$ 2,973,536

United States

Revenues from External Customers [Line Items]

Revenues

1,468,358

1,379,528

1,463,594

CHINA

Revenues from External Customers [Line Items]

Revenues

1,106,679

1,094,061

890,969

Other Asia

Revenues from External Customers [Line Items]

Revenues

340,400

271,797

327,158

TAIWAN, PROVINCE OF CHINA

Revenues from External Customers [Line Items]

Revenues

169,337

188,745

161,479

Europe

Revenues from External Customers [Line Items]

Revenues

154,367

156,194

130,336

Geographic Concentration Risk [Member] | Sales [Member] | United States

Revenues from External Customers [Line Items]

Revenues

3,239,141

3,090,325

2,973,536

All other

Revenues from External Customers [Line Items]

Revenues

$ 0

$ 3,880

^[1]

[1]

Operating Segment and Geographical Information (Details 3) - USD ($) $ in Thousands	Mar. 28, 2020	Mar. 30, 2019
Long-Lived Assets [Line Items]
Long-lived tangible assets	$ 1,259,203	$ 1,366,513
CHINA
Long-Lived Assets [Line Items]
Long-lived tangible assets	166,524	216,342
Geographic Concentration Risk [Member] \| Property, Plant and Equipment \| United States
Long-Lived Assets [Line Items]
Long-lived tangible assets	1,042,587	1,106,705
Geographic Concentration Risk [Member] \| Property, Plant and Equipment \| Other Countries
Long-Lived Assets [Line Items]
Long-lived tangible assets	$ 50,092	$ 43,466

Quarterly Financial Summary (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Mar. 28, 2020	Dec. 28, 2019	Sep. 28, 2019	Jun. 29, 2019	Mar. 30, 2019	Dec. 29, 2018	Sep. 29, 2018	Jun. 30, 2018	Mar. 28, 2020	Mar. 30, 2019	Mar. 31, 2018
Acquisition and Integration related costs	$ 24,000	$ 7,200	$ 7,600	$ 23,100
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain									$ 43,008	$ 0	$ 0
Cost-method Investments, Other than Temporary Impairment									18,339	0	0
Restructuring related charges	4,100	10,300	9,500	24,000	$ 27,900	$ 19,500	$ 500	$ 2,800	$ 47,869	50,714	67,721
Document Fiscal Year Focus									2020
Start-up costs	200	400		100		6,800	5,900	5,300
Income tax expense (benefit)					(11,300)			(32,100)	$ 60,764	(41,333)	57,433
Loss on extinguishment of debt					(6,200)	(1,800)	(48,800)	(33,400)	0	(90,201)	(928)
Quarterly Financial Summary (Unaudited)
Revenues	787,772	869,073	806,698	775,598	680,882	832,330	884,443	692,670	3,239,141	3,090,325	2,973,536
Gross profit	335,781	368,111	323,582	294,289	266,573	338,363	353,514	236,733	1,321,763	1,195,183	1,146,966
Net income (loss)	$ 50,390	$ 161,356	$ 83,038	$ 39,541	$ 61,517	$ 69,517	$ 32,084	$ (29,993)	$ 334,325	$ 133,125	$ (40,288)
Net (loss) income per share:
Basic	$ 0.44	$ 1.39	$ 0.71	$ 0.33	$ 0.51	$ 0.56	$ 0.26	$ (0.24)	$ 2.86	$ 1.07	$ (0.32)
Diluted	$ 0.43	$ 1.36	$ 0.70	$ 0.33	$ 0.50	$ 0.55	$ 0.25	$ (0.24)	$ 2.80	$ 1.05	$ (0.32)